VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-01458
Package ID: USCOURTS-cofc-1_16-vv-01458
Petitioner: Denise Goring
Filed: 2016-11-04
Decided: 2019-11-15
Vaccine: Tdap
Vaccination date: 2015-10-19
Condition: shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 75200

AI-assisted case summary:
On November 4, 2016, Denise Goring, a 60-year-old adult, filed a petition for compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered a left shoulder injury, specifically Shoulder Injury Related to Vaccine Administration (SIRVA), caused by a Tetanus Diphtheria acellular Pertussis (Tdap) vaccination she received on October 19, 2015. On the same date, she also received influenza and shingles vaccines in her left arm. Ms. Goring reported experiencing immediate pain and inflammation in her left shoulder following the vaccinations, which worsened over the subsequent days, leading to significant pain and limited range of motion. She sought medical treatment, including physical therapy, which provided substantial relief, although some residual limitations persisted. The respondent, the Secretary of Health and Human Services, argued that the petition was filed before SIRVA was added to the Vaccine Injury Table, requiring Ms. Goring to prove causation-in-fact rather than relying on a presumed link. The parties also disputed whether the Tdap vaccine or the shingles vaccine was the cause of the injury. Chief Special Master Nora Beth Dorsey issued a ruling on entitlement on May 6, 2019, finding that Ms. Goring had established a prima facie case that the Tdap vaccine caused her SIRVA. The Special Master determined that the respondent bore the burden of proving that unrelated factors caused the injury and had not met this burden. This ruling was based on applying the Althen test for causation-in-fact, considering the SIRVA Qualifications and Aids to Interpretation (QAI) as persuasive, and finding that Ms. Goring met all three prongs of the Althen test: a medical theory connecting the vaccine and injury, a logical sequence of cause and effect, and a proximate temporal relationship. The Special Master also found that a lipoma on Ms. Goring's back was not a cause of her shoulder symptoms. Following the entitlement ruling, a decision on damages was issued on November 15, 2019. The Special Master awarded Ms. Goring $75,200.00 in damages. This award comprised $75,000.00 for pain and suffering and $200.00 for past unreimbursable medical expenses. The Special Master noted that Ms. Goring experienced moderate to severe symptoms for approximately six months, with substantial improvement after physical therapy, but retained some residual limitations. The award was based on prior SIRVA cases with similar symptom severity and duration, and it was determined that Ms. Goring did not meet the burden for future pain and suffering, nor was the cost of a specific exercise machine deemed reasonably necessary.

Theory of causation field:
Denise Goring, age 60, received a Tdap vaccine on October 19, 2015, along with influenza and shingles vaccines in the same left arm. She alleged a Shoulder Injury Related to Vaccine Administration (SIRVA) caused by the Tdap vaccine. The petition was filed on November 4, 2016, prior to SIRVA being added to the Vaccine Injury Table. The case was analyzed as an off-Table, causation-in-fact claim under the Althen standard. Petitioner's counsel was Isaiah Richard Kalinowski. Respondent's counsel was Voris Edward Johnson. Chief Special Master Nora Beth Dorsey ruled on entitlement on May 6, 2019, finding petitioner established a prima facie case under the Althen test (medical theory, logical sequence, proximate temporal relationship) and that the respondent failed to prove unrelated factors (a back lipoma or the shingles vaccine) caused the injury. The Special Master found the SIRVA QAI criteria persuasive for establishing the logical sequence of cause and effect. On November 15, 2019, the Special Master awarded $75,200.00, consisting of $75,000.00 for pain and suffering and $200.00 for past unreimbursable expenses. The award reflected moderate to severe symptoms for six months with significant improvement after physical therapy, but residual limitations.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-01458-1
Date issued/filed: 2018-12-12
Pages: 6
Docket text: PUBLIC ORDER/RULING (Originally filed: 10/31/2018) regarding 65 Findings of Fact & Conclusions of Law ( Signed by Chief Special Master Nora Beth Dorsey. )(mpj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 1 of 6
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1458V
Filed: October 31, 2018
UNPUBLISHED
DENISE GORING,
Special Processing Unit (SPU); Fact
Petitioner, Hearing; Findings of Fact; Onset;
v. Site of Administration; Tetanus
Diphtheria acellular Pertussis (Tdap)
SECRETARY OF HEALTH Vaccine; Additional Non-covered
AND HUMAN SERVICES, Vaccine; Shoulder Injury Related to
Vaccine Administration (SIRVA); No
Respondent. Other Condition or Abnormality
Isaiah Richard Kalinowski, Maglio Christopher & Toale, PA, Washington, DC, for
petitioner.
Voris Edward Johnson, U.S. Department of Justice, Washington, DC, for respondent.
FACT RULING1
Dorsey, Chief Special Master:
On November 4, 2016, Denise Goring (“petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.
§ 300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that she suffered left
shoulder injuries caused by vaccinations she received on October 19, 2015. Petition at
1-2. The case was assigned to the Special Processing Unit of the Office of Special
Masters. For the reasons discussed below, the undersigned finds that petitioner’s
Tetanus Diphtheria acellular Pertussis (“Tdap”) and shingles vaccines were
administered in her left arm; that the onset of petitioner’s left shoulder injuries occurred
within 48 hours of her October 19, 2015 vaccinations; and that a lipoma on petitioner’s
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2012).

Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 2 of 6
back was incidental and was not a condition or abnormality that explained her
symptoms.
I. Procedural History Prior to Hearing
On November 4, 2016, Ms. Goring filed her petition (ECF No. 1). On the same
day, she filed medical records marked as Exhibits 1-6 (ECF No. 4). She filed additional
medical records, Exhibit 7, and a Statement of Completion on November 28, 2016 (ECF
Nos. 9 and 10). The initial status conference was held on January 10, 2017 and
respondent was directed to file a status report concerning the completeness of the
records and how respondent intended to proceed in this case (ECF No. 11).
On February 3, 2017, petitioner filed an additional medical record marked as
Exhibit 8 and an affidavit designated Exhibit 9 (ECF No. 12). On February 24, 2017,
respondent filed a status report identifying missing records needed to determine
respondent’s position in this case (ECF No. 13). On the same day, petitioner filed a
status report in response concerning the medical records identified by respondent and
stating that petitioner sent a demand letter to respondent on February 24, 2017 (ECF
No. 14).
On February 27, 2017, the undersigned issued a scheduling order directing
respondent to file a status report proposing appropriate next steps (ECF No.15). From
March to June 2017 the parties engaged in discussions attempting to informally resolve
this matter (ECF Nos. 16-23). On July 20, 2017, petitioner filed a status report
informing the court that the parties had been unable to resolve the matter informally and
proposing that the court schedule a deadline for the filing of respondent’s Rule 4(c)
Report (ECF No. 25). On July 21, 2017, petitioner filed additional medical records as
Exhibit 10 (ECF No. 28).
On August 10, 2017, respondent filed a Rule 4(c) Report (ECF No. 29). The
court scheduled a status conference to discuss with the parties how to proceed. Before
the status conference took place, on August 28, 2017, petitioner filed a motion for
summary judgment (ECF No. 30). The August 28, 2017 status conference was
cancelled, respondent filed a response to the summary judgment motion (ECF No. 31),
and petitioner filed a reply (ECF No. 32). Petitioner filed an additional affidavit on
September 20, 2017 (ECF No. 33).
On October 4, 2017, the undersigned denied the summary judgment motion
(ECF No. 34) and directed petitioner to file additional affidavits, medical records, and an
expert report (ECF No. 35). On December 13, 2017, petitioner filed additional medical
records, a detailed affidavit, and medical literature (ECF Nos. 39 and 40). Also on
December 13, 2017, petitioner filed a status report and request for a status conference
(ECF No. 41).
On January 23, 2018, the undersigned held a status conference with counsel for
both parties. On January 24, 2018, petitioner filed a status report confirming that she
sent a detailed counter-offer to respondent (ECF No. 44). On February 1, 2018, the
undersigned issued an order directing petitioner to obtain an expert report addressing a
lipoma on petitioner’s back as an alternative cause of her shoulder condition.
Scheduling Order, issued Feb. 1, 2018 (ECF No. 45). In the February 1, 2018 order,
2

Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 3 of 6
the undersigned further stated that absent additional evidence, the undersigned was
inclined to rule that respondent had not met his burden of proving alternate causation, in
this case whether a vaccine not covered by the Vaccine Act had caused petitioner’s
injury.
On April 24, 2018, petitioner filed medical records from Dr. Ellis Nam of Chicago
Orthopaedics & Sports Medicine, S.C. (ECF No. 50-2). On May 30, 2018, petitioner
filed a May 18, 2018 addendum to Dr. Nam’s earlier records (ECF No. 53-2). On May
30, 2018, the parties and OSM staff attorneys held a status conference to discuss how
to proceed. On June 1, 2018, the undersigned issued an order determining that the
case should proceed to a hearing to resolve the onset of petitioner’s symptoms, the site
of administration of petitioner’s vaccinations, and whether a lipoma on petitioner’s back
was a condition or abnormality that would explain her symptoms (ECF No. 54). A fact
hearing was thereafter scheduled for September 18, 2018.
II. Fact Hearing and Ruling
A fact hearing was held in Washington, D.C., on September 18, 2018. Ms.
Goring was the sole witness and she appeared in person with her attorney. At the
conclusion of the hearing, the undersigned informed the parties that she intended to
issue a ruling from the bench. The undersigned stated that her ruling would resolve the
site of vaccine administration, whether the onset of petitioner’s symptoms occurred
within 48 hours of vaccination, and the role of a lipoma on petitioner’s back.
Effective for petitions filed beginning on March 21, 2017, SIRVA is an injury listed
on the Vaccine Injury Table (“Table”). See Vaccine Injury Table: Qualifications and Aids
to interpretation. 42 C.F.R. § 100.3(c)(10). Although petitioner’s claim was filed before
SIRVA was added to the Table, and thus cannot be found to be a Table SIRVA claim,
the undersigned’s findings were informed by the Qualifications and Aids to Interpretation
for SIRVA criteria used to evaluate such claims. The criteria are as follows:
A vaccine recipient shall be considered to have suffered SIRVA if such
recipient manifests all of the following: (i) No history of pain, inflammation
or dysfunction of the affected shoulder prior to intramuscular vaccine
administration that would explain the alleged signs, symptoms,
examination findings, and/or diagnostic studies occurring after vaccine
injection; (ii) Pain occurs within the specified time-frame; (iii) Pain and
reduced range of motion are limited to the shoulder in which the
intramuscular vaccine was administered; and (iv) No other condition or
abnormality is present that would explain the patient’s symptoms (e.g.
NCS/EMG or clinical evidence of radiculopathy, brachial neuritis,
mononeuropathies, or any other neuropathy).
Id.; see also National Vaccine Injury Compensation Program: Revisions to the
Vaccine Injury Table, 80 Fed. Reg. 45132, Notice of Proposed Rulemaking, July
29, 2015 (citing Atanasoff S, Ryan T, Lightfoot R, and Johann-Liang R, 2010,
Shoulder injury related to vaccine administration (SIRVA), Vaccine 28(51):8049-
8052).
3

Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 4 of 6
With these factors in mind, the undersigned made the following preliminary
findings of fact:
There are several issues that require this fact hearing today. They include -- the
several fact issues, they include the site of administration, onset, and the role of
the lipoma.
First, as to the site of the tetanus and shingles vaccine injections, I find that they
were administered into Petitioner's left arm. I base this on a number of medical
record -- a number of pieces of medical record evidence. First, the Petitioner's
Exhibit 1, the vaccine administration record shows that the Petitioner received
three vaccines on October the 19th, 2015, including the TDaP vaccine. Secondly,
Petitioner's Exhibit 3 at 42, Dr. Noriega charted at that visit, December 22nd of
2015, that the Petitioner had left arm pain after two shots. Similarly, Dr.
Townsend documented that the Petitioner complained of left shoulder pain that
began after receiving two immunizations in the left arm. That was documented
January 26th, 2016. Exhibit 3 at page 326.
Similarly, the Center for Progressive Health, that's the natural physician,
documented on February the 2nd, 2016, left shoulder pain following tetanus and
shingles shots in left deltoid in October. Exhibit 2 at pages 3 and 4. Additionally,
that is consistent with the Petitioner's testimony here today. Also, the medical
records by the physical therapist, Shawn White, Exhibit 5 at pages 54 and 56. All
of these records are consistent, showing the Petitioner consistently reported to
healthcare providers, different healthcare providers, who all documented that she
received her tetanus and shingles vaccines and that they were administered in
her left arm. For these reasons, I find the site of her tetanus and shingles
vaccines to be her left deltoid.
With regard to onset, I find that the onset of pain, the initial manifestation of pain
in Petitioner began within 48 hours. I base this on a number of pieces of
evidence. I think the strongest evidence is that written by Dr. Perrott on February
18th, 2016, when he documented "injections in left deltoid since October" and
"since then" had pain in left shoulder region. Exhibit 14 at page 3. This is also
documented by Dr. Noriega on December 22nd, 2015, at Exhibit 3 at page 42;
however, he used the words "left arm pain after two shots." Similarly, Dr.
Townsend Scott documented left shoulder pain that began after receiving two
immunizations in the left arm. Exhibit 3 at 326. And, again, the Center for
Progressive Health, "left shoulder pain following tetanus and shingles shots in left
deltoid" in October. Exhibit 2 at pages 3 and 4. Additionally, I find that Petitioners'
testimony here today to be consistent with a very detailed explanation as to the
pain and then the weakness and reduced range of motion that she experienced. I
find that her pain began within 48 hours of receiving the tetanus and shingles
shots in her left arm.
4

Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 5 of 6
The next issue is the role of the lipoma. Ms. Goring was seen in the Mercy
Hospital Emergency Room on January 19th, 2016, by Dr. Krishna [Raol] and Dr.
Michael Joo . . . . On intake, Petitioner reported that she had been having left
shoulder pain after she received two immunizations in that arm about two months
ago. A CT of the chest was done which showed a large [fat] density mass deep
to the left serratus anterior and latissimus dorsi muscles. The impression was
"Fat density mass overlying the posteriolateral left chest wall to the same
muscles, which likely represents a lipoma." The diagnosis was "Shoulder pain
likely related to rotator cuff pathology, possibly related to large lipoma." And Ms.
Goring was instructed to follow up with her PCP. Exhibit 3 at page 298. Ms.
Goring did follow up and had additional evaluation. She saw Dr. Perrott on
February 18th, 2016. Dr. Perrott diagnosed her with an incidental lipoma and
noted that the Petitioner agrees that excision of this is unlikely to change her
shoulder problem. He charted "Shoulder, questionable rotator cuff syndrome as
cause of discomfort," and referred her to PT. Exhibit 14 at 3.
Following that, she saw Dr. Nam in March, March 8th, 2018. Dr. Nam
documented, "She is inquiring if a lipoma on her back resulted in her left shoulder
condition. I believe her lipoma seen in her CT scan of her left upper back was
unrelated to her left shoulder condition she developed after her vaccination."
Exhibit 24 at page 3. Dr. Nam also documented an addendum on May 18th,
2018, in which he states:
Patient has an incidental lipoma on her back which was unrelated to her
left shoulder condition she developed as a result of the tetanus/shingles
shot in her left shoulder on October 2015. The lipoma's location is not on
her back and not on her left shoulder. They are in separate, distinct
anatomical locations in her body. As a result, the lipoma has no
relationship to her left shoulder and has no influence in Denise developing
left shoulder pain after her injection she received in October 2015.
Exhibit 24 at page 2.
Thus, I find that Dr. Nam has clarified the condition of lipoma, which was raised
as a possible issue by the emergency room physicians, and I find that his
opinions are reasonable, valid, and credible, as well as persuasive, and, thus, I
find, as Dr. Nam did, I find that his opinion that the lipoma is incidental and not
related or causally related to her shoulder injury related to vaccine administration
or shoulder injury, I find that it is not related.
These are my opinions or my factual findings, and that is the end of my factual
findings.
5

Case 1:16-vv-01458-UNJ Document 68 Filed 12/12/18 Page 6 of 6
Transcript of September 18, 2018 Hearing, ECF No. 63, at 82-86.3
III. Closing of the Record Regarding Entitlement
Following the hearing, the undersigned took judicial notice of two articles
pertaining to causation of vaccine-related shoulder injuries which were filed as court
exhibits. These articles are: B. Atanasoff et al., Shoulder injury related to vaccine
administration (SIRVA), 28 Vaccine 8049 (2010), filed as Court Exhibit I, and M. Bodor
and E. Montalvo, Vaccination Related Shoulder Dysfunction, 25 Vaccine 585 (2007),
filed as Court Exhibit II (ECF No. 64).
The parties have been provided until December 7, 2018 to provide additional
evidence concerning entitlement or any response to the court exhibits, and memoranda
addressing the implications of petitioner’s receipt of a vaccine covered by the Vaccine
Program and a non-covered vaccine in her injured arm. Id. Thereafter, the record will
close and the undersigned will issue a decision or ruling on entitlement.
IV. Conclusion
In light of all of the above, and in view of the submitted evidence, including the
medical records, credible witness testimony, and findings of fact, the undersigned
finds that the site of administration of petitioner’s Tdap and shingles vaccinations
was her left arm; that the onset of petitioner’s right shoulder injuries was within
48 hours of vaccination; and that petitioner’s back lipoma was incidental and not
a condition or abnormality that would explain her symptoms.
A scheduling order has been issued granting the parties until December 7, 2018
to submit any additional evidence on entitlement and allowing the parties to file
memoranda of law addressing the implications of the fact that petitioner received both a
vaccine covered by the Vaccine Program and a non-covered vaccine in her injured
arm. (ECF No. 64). After the record closes, the undersigned intends to issue a
decision or ruling on entitlement based on all the evidence submitted into the
record, and consistent with the findings set forth in this ruling.
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
3 This ruling is not a verbatim transcript of the undersigned’s bench ruling. It includes minor changes for
the purpose of readability.
6

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_16-vv-01458-2
Date issued/filed: 2019-08-20
Pages: 28
Docket text: PUBLIC DECISION (Originally filed: 05/06/2019) regarding 71 Ruling on Entitlement ( Signed by Chief Special Master Nora Beth Dorsey. )(mpj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 1 of 28
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1458V
Filed: May 6, 2019
UNPUBLISHED
DENISE GORING,
Petitioner, Special Processing Unit (SPU);
v. Ruling on Entitlement; Decision after
Fact Hearing and Ruling; Causation-
SECRETARY OF HEALTH AND In-Fact; Tetanus Diphtheria acellular
HUMAN SERVICES, Pertussis (Tdap) Vaccine; Additional
Non-covered Vaccine; Alternative
Respondent. Causation Burden of Proof; Shoulder
Injury Related to Vaccine
Administration (SIRVA)
Isaiah Richard Kalinowski, Maglio Christopher & Toale, PA, Washington, DC, for
petitioner.
Voris Edward Johnson, U.S. Department of Justice, Washington, DC, for respondent.
RULING ON ENTITLEMENT1
Dorsey, Chief Special Master:
On November 4, 2016, Denise Goring (“petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.
§ 300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that she suffered left
shoulder injuries caused by vaccinations she received on October 19, 2015. Petition at
1 The undersigned intends to post this ruling on the United States Court of Federal Claims' website. This
means the ruling will be available to anyone with access to the internet. In accordance with Vaccine
Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the
disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned
agrees that the identified material fits within this definition, the undersigned will redact such material from
public access. Because this unpublished ruling contains a reasoned explanation for the action in this
case, undersigned is required to post it on the United States Court of Federal Claims' website in
accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management
and Promotion of Electronic Government Services).
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2012).

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 2 of 28
1-2. Petitioner received two vaccines, one covered and one non-covered, in the arm
where she suffered an injury.
The parties dispute whether this case may be analyzed as a Table case or
petitioner must establish causation-in-fact; whether petitioner has established that a
covered vaccine caused her injury; and who has the burden of proof as to whether
factors unrelated to the covered vaccine caused her injury and whether this has been
established in this case. For the reasons stated herein, the undersigned finds that,
whether analyzed as a Table case or causation-in-fact case, the petitioner has
established a prima facie case that she suffered a shoulder injury caused by a covered
vaccine. The undersigned further determines that respondent has the burden of proof
to show that unrelated factors caused petitioner’s injury and that he has not met this
burden.
I. Procedural History
On November 4, 2016, Ms. Goring filed her petition (ECF No. 1). On the same
day, she filed medical records marked as Exhibits 1-6 (ECF No. 4). The case was
assigned to the Special Processing Unit of the Office of Special Masters. She filed
additional medical records, Exhibit 7, and a Statement of Completion on November 28,
2016 (ECF Nos. 9 and 10). The initial status conference was held on January 10, 2017
and respondent was directed to file a status report concerning the completeness of the
records and how respondent intended to proceed in this case (ECF No. 11).
On February 3, 2017, petitioner filed an additional medical record marked as
Exhibit 8 and an affidavit designated Exhibit 9 (ECF No. 12). On February 24, 2017,
respondent filed a status report identifying missing records needed to determine
respondent’s position in this case (ECF No. 13). On the same day, petitioner filed a
status report in response concerning the medical records identified by respondent and
stating that petitioner sent a demand letter to respondent on February 24, 2017 (ECF
No. 14).
On February 27, 2017, the undersigned issued a scheduling order directing
respondent to file a status report proposing appropriate next steps (ECF No.15). From
March to June 2017 the parties engaged in discussions attempting to informally resolve
this matter (ECF Nos. 16-23). On July 20, 2017, petitioner filed a status report
informing the court that the parties had been unable to resolve the matter informally and
proposing that the court schedule a deadline for the filing of respondent’s Rule 4(c)
Report (ECF No. 25). On July 21, 2017, petitioner filed additional medical records as
Exhibit 10 (ECF No. 28).
On August 10, 2017, respondent filed a Rule 4(c) Report (ECF No. 29) asserting
that petitioner had not established entitlement to compensation. The court scheduled a
status conference for August 28, 2017 to discuss with the parties how to proceed.
Before the status conference took place, on August 28, 2017, petitioner filed a motion
for summary judgment (ECF No. 30). The August 28, 2017 status conference was
2

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 3 of 28
cancelled. Respondent filed a response to the summary judgment motion (ECF No.
31), and petitioner filed a reply (ECF No. 32). Petitioner filed an additional affidavit on
September 20, 2017 (ECF No. 33).
On October 4, 2017, the undersigned denied the summary judgment motion
(ECF No. 34) and directed petitioner to file additional affidavits, medical records, and an
expert report (ECF No. 35). On December 13, 2017, petitioner filed additional medical
records, a detailed affidavit, and medical literature (ECF Nos. 39 and 40). Also on
December 13, 2017, petitioner filed a status report and request for a status conference
(ECF No. 41).
On January 23, 2018, the undersigned held a status conference with counsel for
both parties. On January 24, 2018, petitioner filed a status report confirming that she
sent a detailed counter-offer to respondent (ECF No. 44). On February 1, 2018, the
undersigned issued an order directing petitioner to obtain an expert report addressing a
lipoma on petitioner’s back as an alternative cause of her shoulder condition.
Scheduling Order, issued Feb. 1, 2018 (ECF No. 45). In the February 1, 2018 order,
the undersigned further stated that absent additional evidence, the undersigned was
inclined to rule that respondent had not met his burden of proving alternative causation.
Id.
On April 24, 2018, petitioner filed medical records from Dr. Ellis Nam of Chicago
Orthopaedics & Sports Medicine, S.C. (ECF No. 50-2). On May 30, 2018, petitioner
filed a May 18, 2018 addendum to Dr. Nam’s earlier records (ECF No. 53-2). On May
30, 2018, the parties and OSM staff attorney held a status conference to discuss how to
proceed. On June 1, 2018, the undersigned issued an order determining that the case
should proceed to a hearing to resolve the onset of petitioner’s symptoms, the site of
administration of petitioner’s vaccinations, and whether a lipoma on petitioner’s back
was a condition or abnormality that would explain her symptoms (ECF No. 54). A fact
hearing was thereafter scheduled for September 18, 2018.
On September 18, 2018, a fact hearing was held in Washington, D.C. Transcript
of Hearing held on September 18, 2019 (“Tr.”) (ECF No. 63). Ms. Goring was the sole
witness and she appeared in person with her attorney. At the conclusion of the hearing,
the undersigned issued a ruling from the bench. On the same day, the undersigned
issued a scheduling order directing the parties to consult and determine whether, in light
of the resolution of the disputed factual issues, they were able to resolve this matter
through negotiations. Scheduling Order, issued Sept. 18, 2018 (ECF No. 60). On
October 3, 2018, the parties filed a joint status report stating that they had attempted in
good faith to resolve this matter but were unable to do so. Joint Status Report, filed
Oct. 3, 2018 (ECF No. 61).
On October 31, 2018, the undersigned issued a fact ruling memorializing the
bench ruling. Fact Ruling, 2018 WL 6539219 (Fed. Cl. Spec. Mstr. Oct. 31, 2018) (ECF
No. 65). The undersigned first determined that petitioner’s Tetanus Diphtheria acellular
3

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 4 of 28
Pertussis (“Tdap”) and shingles vaccines were administered in her left arm. Id. at *3.
Next, the undersigned determined that the onset of petitioner’s left shoulder injuries
occurred within 48 hours of her October 19, 2015 vaccinations. Id. at *4.3 Finally, the
undersigned determined that a lipoma on petitioner’s back was incidental and not a
condition or abnormality that explained her symptoms. Id.
On October 31, 2018, the undersigned issued a scheduling order filing as court
exhibits two articles pertaining to causation of vaccine-related shoulder injuries.
Scheduling Order, issued Oct. 31, 2018 (ECF No. 64). These articles are: S. Atanasoff
et al., Shoulder injury related to vaccine administration (SIRVA), 28 Vaccine 8049
(2010), filed as Court Exhibit I, and M. Bodor and E. Montalvo, Vaccination Related
Shoulder Dysfunction, 25 Vaccine 585 (2007), filed as Court Exhibit II (ECF No. 64).
In the October 31, 2018 scheduling order, the parties were given until December
7, 2018 to provide additional evidence concerning entitlement or any response to the
court exhibits, and to file memoranda addressing the implications of petitioner’s receipt
of a vaccine covered by the Vaccine Program as well as a non-covered vaccine in her
injured arm. Id. After that time, the parties were informed, the record concerning
entitlement would close and the undersigned intended to issue a decision or ruling
concerning entitlement. Id.
In addition, the undersigned informed the parties that as previously indicated in a
February 1, 2018 scheduling order (ECF No. 45), the undersigned was inclined to rule
in this case that respondent had the burden of proving alternative causation and had not
met that burden. Scheduling Order, issued Oct. 31, 2018 (ECF No. 64).
The undersigned cited the decision of the United States Court of Appeals for the
Federal Circuit in Walther v. Sec’y of Health and Human Servs., 485 F. 3d 1146 (Fed.
Cir. 2007), as establishing that once petitioner has established a prima facie case, the
government bears the burden of establishing alternative causation by a preponderance
of the evidence. Id. The undersigned noted that she had previously applied the
reasoning set forth in Walther to find, in a case where a petitioner received both a
covered and non-covered vaccine in the injured arm, that the government bears the
burden of establishing that the non-covered vaccine caused the injury.4 Id. The
undersigned informed the parties that absent additional evidence, she was inclined to
rule in this case that petitioner had established a prima facie case and respondent had
3 The October 31, 2018 fact ruling contained a typographical error in the conclusion, stating that onset of
petitioner’s right shoulder injuries was within 48 hours of vaccination. Id. at *4. As the remainder of the
fact ruling makes clear, petitioner’s injuries were to her left, not right, shoulder.
4 The previous decision involving this issue is Zebofsky v. Sec’y of Health & Human Servs., No. 15-
1084V, 2017 WL 7051381 (Fed. Cl. Spec. Mstr. Sept. 28, 2017) (applying Walther and determining that
respondent had not provided evidence to establish an alternative cause of petitioner’s injury in a case
also involving two vaccines, one covered and one non-covered, in the same arm). No motion for review
was filed following the decision.
4

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 5 of 28
not met his burden of proving that the non-covered vaccine, rather than the covered
vaccine, caused petitioner’s injury. Id.
Finally, in the October 31, 2018 scheduling order, the undersigned noted that
respondent had, in his Rule 4(c) Report, appeared to argue that petitioner alleged that a
flu vaccine in her right shoulder had caused a SIRVA in her left shoulder.5 Id. The
undersigned noted that in a February 1, 2018 scheduling order (ECF No. 45), the
undersigned indicated that while the petition may have been ambiguous as to which
vaccine was alleged to have caused petitioner’s injury, it appeared that the claim was
based on the Tdap vaccine. Id. The undersigned invited the parties to file additional
evidence on this matter as well. Id.
On December 4, 2018, petitioner filed a motion for summary judgment (ECF No.
66). On December 7, 2018, respondent filed a response to the court’s October 31,
2018 scheduling order (ECF No. 67). On December 13, 2018, respondent filed a
response to petitioner’s December 4 summary judgment motion (ECF No. 69). On
December 20, 2018, petitioner filed a reply (ECF No. 70). This case is now ripe for a
decision on petitioner’s second summary judgment motion and a ruling on entitlement.
II. Factual History
Denise Goring was 60 years old when she received influenza, Tetanus
Diphtheria acellular Pertussis (“Tdap”), and shingles vaccines at a Department of
Defense installation in Texas on October 19, 2015. Petitioner’s Exhibit (“Pet. Ex.”) 1 at
1; Pet. Ex. 11 at 1; Pet. Ex. 15 at 1. The Vaccine Administration Record filed as Pet.
Ex. 1 lists all three of these vaccines as having been given on that date, and lists the
manufacturer and lot number, but does not list the vaccination sites. Pet. Ex. 1.
Petitioner asserts in her detailed fact affidavit that the influenza vaccination was
administered in her right arm, while the Tdap and shingles vaccinations were
administered in her left arm. Pet. Ex. 15 at ¶ 2. She states that she remembers which
vaccinations were administered into which arm because of the circumstances of their
administration. Pet. Ex. 15 at ¶ 3. Specifically, she states that she went to the clinic
that day only to receive a flu shot, which the technician injected into her right shoulder
first. Id. However, after administering the flu shot, the technician inquired how long it
had been since petitioner had a tetanus booster. Id. at ¶ 4.
Petitioner asserts that the technician convinced her to have a tetanus, or Tdap,
shot, which she administered into petitioner’s upper left arm since she had already
administered a flu shot into petitioner’s right shoulder. Id. As petitioner and the
5 Respondent’s argument is somewhat difficult to follow but appears to be that because petitioner’s initial
affidavit mentioned only the arm of vaccination of her flu shot, which was administered into her right arm,
that meant that petitioner was alleging that a flu shot in her right arm caused a SIRVA in her left shoulder.
To the extent that this is respondent’s interpretation, the undersigned does not agree with respondent that
petitioner asserts a flu shot in her right arm caused a SIRVA in her left shoulder.
5

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 6 of 28
technician continued to talk, the technician persuaded her to get a shingles vaccination
as well, which was administered into petitioner’s left arm. Id. at ¶ 5. Petitioner states
that because of these circumstances, she is confident that she accurately recalls which
vaccinations were administered into which arm. Id. at ¶ 6. On October 19, 2015,
petitioner also presented to Dr. Judy Rattan in the optometry clinic at Randolph Air
Force Base for an eye exam. Pet. Ex. 4 at 209.
Prior to the October 19, 2015 vaccinations, petitioner had no prior history of
shoulder pain or shoulder injury. See generally Pet. Ex. 3, Pet. Ex. 4, Pet. Ex. 7.
Petitioner states in her detailed affidavit that she began to experience “distinct pain and
inflammation swelling almost immediately” after the vaccines were administered. Pet.
Ex. 15 at ¶ 7. Petitioner testified that at the moment of injection, she “didn’t feel
anything on my right side where my flu shot was . . . I felt like a tingling on my left side .
. . . . [after the administration of] both the tetanus and the shingles [vaccines].” Tr. 10-
11. She testified that she began to experience soreness in her left shoulder
“immediately pretty much after she administered those two [tetanus and shingles
vaccines] in my left arm . . . what kind of startled me, I noticed that it was kind of
inflamed.” Tr. 11.
Petitioner states that the pain began before she left the clinic, that she inquired
about it and was told it was normal and would go away. Pet. Ex. 15 at ¶ 7. Petitioner
states that the area surrounding the injection site on her upper left arm was noticeably
swollen by the time she returned to the place where she was staying in Texas. 6 Id.
Petitioner’s detailed affidavit states that the day following the vaccine “the pain [in
her left arm] became so bad, I knew there was a problem.” Id. at ¶ 8. Petitioner states
that she telephoned the clinic and was again assured that the pain was normal and
would go away. Id. Petitioner states that by the second day after vaccination, the pain
remained and she also had difficulty with movement in her left arm. Id. at ¶ 9.
Petitioner states that she again called the clinic and was told not to worry and that the
pain could be expected to continue for the next two weeks before going away. Id.
In her detailed affidavit, petitioner states that by one week following vaccination,
she “could not move my left arm nearly at all, and it was basically incapacitated from
that point onward.” Id. at ¶ 10. She states that she “could barely lift my arm to comb my
hair, and could hardly use my left hand at all.” Id. After two weeks passed and she was
still in pain, she called the facility again but “they again dismissed my concerns, stating
that sometimes it can take even longer for the pain to go away.” Id. at ¶ 11. She states
that she “could see that the staff at the clinic were not taking this injury seriously [and]
decided I needed to set up an appointment with my doctor in Chicago for when I
returned there from Texas.” Id.
6 At the hearing, petitioner explained that she lives in Chicago but visits San Antonio twice a year to visit
her grown children and that while she is there she sees her dentist and medical providers. Tr. 55.
6

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 7 of 28
Petitioner asserts that she does not have records from October or November
documenting her injury because her concerns were not taken seriously initially and
because she was unable to obtain an appointment when she sought evaluation and
treatment. Pet. Ex. 15 at ¶ 21. In her detailed affidavit, petitioner states that she called
her primary care physician in Chicago seeking an appointment before the end of
November, but the soonest she could obtain an appointment was in late December.
Pet. Ex. 15 at ¶ 12. Petitioner states that she was finally able to see Dr. Karen Noriega
on December 22, 2015. Id. at ¶ 13.
On December 22, 2015, petitioner presented to Dr. Karen Noriega at Mercy
Hospital and Medical with a chief complaint of “LT [left] ARM PAIN AFTER 2 SHOTS x
2 MONTHS; GETTTING WORST.” Pet. Ex. 3 at 42. In the same paragraph, the visit
notes state that she complained of “left arm pain after shingles vaccination 10/2015 in
texas military base, pt [patient] feels pain is worsening where she cannot lift her left arm
over her head.” Id. While the medical record reflects that petitioner attributed her pain
to her shingles vaccination, petitioner testified that she “mentioned all three” vaccines
that she had received. Tr. 21.
On examination, her left arm was found to have decreased range of motion and
tenderness to deep palpation. Id. at 45. She could not lift her left arm above her head
and her left arm was weaker than her right arm. Id. Dr. Noriega ordered a CT scan of
petitioner’s left shoulder. Id. Petitioner states that Dr. Noriega prescribed pain
medication and referred her for an MRI; however, her insurance declined coverage for
the MRI because she had not first had an x-ray. Pet. Ex. 15 at ¶ 14.
On January 19, 2016, petitioner presented to the emergency room at Mercy
Hospital and Medical Center with a chief complaint of left arm pain. Pet. Ex. 3 at 278.
She complained of left shoulder pain “ongoing since 10/2015, states she first felt pain
after she received vaccine for shingles. Since then has had significant pain and has
experienced limited range of motion of LUE [left upper extremity, or arm] and shoulder.
Id. at 298. On examination, she was found to have mild tenderness to palpation and
limited range of motion in her left shoulder. Id. She was given shoulder x-rays, which
did not identify any fracture or dislocation. Id. at 294. She was also given a chest CT,
which noted a fat density mass “which likely represents a lipoma.” Id. at 296.
The examining physician found that the pain was reproducible with range of
motion of the left shoulder. She was diagnosed with left shoulder pain not otherwise
specified, left posterior chest wall lipoma, and possible adrenal lipoma. The [doctor]
noted that the pain was “chronic in nature since 10/2015 limiting movement” and
determined that the shoulder pain was “likely related to rotator cuff pathology, possibly
related to large lipoma.” Pet. Ex. 3 at 298. Petitioner was discharged and directed to
follow up with her primary care physician. Id.
Petitioner states that the “lipoma was on my back and side, essentially, below my
shoulder and scapula . . . not near my shoulder.” Id. Petitioner asserts that the lipoma
7

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 8 of 28
“has been present on my back for about 15 years, and has never caused me adverse
symptoms or concern.” Pet. Ex. 15 at ¶ 18. In her detailed affidavit, executed on
December 11, 2017, petitioner asserts that “[t]o this day, the Lipoma is still on my back.”
Pet. Ex. 15 at ¶ 20. She asserts that as her injury developed and later improved, the
lipoma has remained there. Id.
On January 26, 2016 petitioner presented to Dr. Kimberly Townsend-Scott. Pet.
Ex. 3 at 326. At this visit, she complained of left shoulder pain that she reported began
after receiving two immunizations in her left arm. Id. Petitioner reported having been
seen in the emergency room for this and directed to follow up with her doctor, but
reported she was unable to get an appointment with her primary doctor, Dr. Dhir, until
March 2016. Id. She was diagnosed with left arm pain, lipoma, adrenal mass, and
hypertension. Id. at 331. Dr. Townsend-Scott referred her to surgery for evaluation and
possible excision of the lipoma. Id. at 332. For her shoulder pain, Dr. Townsend-Smith
discussed physical therapy if excision of the lipoma did not provide relief. Id.
On February 2, 2016, petitioner was seen by Dr. Nicholas Leroy at the Center for
Progressive Health. Pet. Ex. 2 at 3-4; Tr. 74. The visit notes reflect that petitioner was
seen for left shoulder pain following tetanus and shingles shots in her left deltoid in
October. Pet. Ex. 2 at 4. Petitioner reported that she could not raise her left arm above
horizontal. She reported fever and night sweats since the vaccinations. Id. On
examination, she was found to be severely restricted in internal and external rotation in
her left shoulder. She was found to have tenderness in her left deltoid muscle, left
subscapularis muscle, and left infraspinatus muscle. Id. Dr. Leroy assessed petitioner
as having left “rot. [rotator] cuff syndrome 2° [secondary] to Oct 2015 vaccine shots [in
left] deltoid.” Id. at 3. Myofascial release for rotator cuff or physical therapy was
recommended. Id.
On February 18, 2016, petitioner presented to Dr. Andrew Perrott. Pet. Ex. 14 at
3. She reported that she had injections in her left deltoid in October and since then had
pain in her left shoulder region, particularly with certain movements. Id. She had a
deep-seated lipoma of the left chest wall, but it was not tender. Id.
On physical examination, petitioner was found to have restriction in left shoulder
movement with abduction of about 60 degrees and extension of 90 degrees. Id. at 4.
Dr. Perrott diagnosed petitioner with an “incidental lipoma” and noted that petitioner
“agrees that excision of this [is] unlikely to change [her] shoulder problem.” Id. He
added, “Shoulder ? rotator cuff syndrome as cause of her discomfort.” Id. Dr. Perrott
discussed referral to an orthopedist or physical therapy and petitioner stated that she
would like to try physical therapy first. Id. Dr. Perrott ordered physical therapy
consultation and treatment. Id. at 7.
On March 28, 2016, petitioner underwent an initial physical therapy evaluation for
her left shoulder pain. Pet. Ex. 5 at 54. She reported that in the end of October 2015
she had tetanus and shingles vaccines in her left arm and after two weeks the pain in
8

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 9 of 28
her left shoulder increased. Id. She reported noticing tissue changes in her left
shoulder following the shot and having pain. Id. She initially had pain at rest in her left
shoulder, but at the time of evaluation she experienced pain only with movement. Id. at
56. She reported limited range of motion when putting her arm behind her back and
reaching over her head. Id. On examination, she was found to have limited and painful
range of motion and reduced strength in her left shoulder. Id. at 55. She had
tenderness to palpation over the insertion of her left deltoid and her upper trapezius
muscle and positive signs on Hawkins and Kennedy impingement tests. Id.
On April 18, 2016, petitioner presented to Universal City Family Practice in
Universal City, TX, to follow up on labs. Pet. Ex. 7 at 3. The visit notes are handwritten
and difficult to read. There appears to be a mention of her left shoulder problem, but
the notes are unclear as to what was discussed or recommended. Id. at 4.
On November 7, 2016, petitioner was seen by Dr. Kokebie for a rheumatology
consultation with a chief complaint of right wrist and right knee pain. Pet. Ex. 10 at 1.
Petitioner reported that her right knee pain started in August after a car accident. Id.
Petitioner reported that the right wrist pain “started 2 months ago since she was favoring
her right arm due to tetanus and zoster vaccines in the left shoulder [which] was [very]
painful.” Id.
On March 8, 2018, petitioner presented to Dr. Ellis Nam of Chicago Orthopaedics
and Sports Medicine, S.C. for examination. Pet. Ex. 23 at 3. She reported left shoulder
pain that began “2 years ago, October 2015, after she had a tetanus/shingles shot in
her left shoulder. No prior problems left shoulder prior to the injection.” Id.
Dr. Nam assessed petitioner as having left shoulder pain following tetanus and
shingles vaccinations in October 2015, with “possible [rotator] cuff tear.” Id. at 4. He
recommended an MRI of the left shoulder to rule out a rotator cuff tear, but noted that
petitioner did not want a left shoulder MRI. Id. Dr. Nam noted that petitioner inquired
whether a lipoma on her back resulted in her shoulder condition. He stated, “I believe
her lipoma seen in her ct scan of her left upper back was unrelated to her left shoulder
condition she developed after her vaccination.” Id.
On May 18, 2018, Dr. Nam added an addendum to petitioner’s medical records.
Pet. Ex. 24. On May 30, 2018, petitioner filed Exhibit 24 and Exhibit 25, the curriculum
vitae of Ellis Kevin Nam, M.D. Exhibit 25 was labeled in CM/ECF as “Expert CV” (ECF
No. 53). In Exhibit 24, Dr. Nam stated:
Patient has an incidental lipoma on her back which was unrelated to her left
shoulder condition she developed as a result of the tetanus/shingles shot in
her left shoulder on October, 2015. The lipoma’s location is on her back
and NOT on her left shoulder. They are in separate distinct anatomic
locations in her body. As a result, the lipoma has no relationship to her left
shoulder and has no influence in [petitioner] developing left shoulder pain
after her injection she received on October, 2015.
9

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 10 of 28
Pet. Ex. 24 at 1.
III. Parties’ Arguments
a. Petitioner’s Arguments
In her summary judgment motion filed on December 4, 2018 (“Petitioner’s
Second MSJ”) (ECF No. 66-1), petitioner asserts that she has satisfied the
requirements of § 13 of the Vaccine Act by establishing the factual matters set forth in
§ 11(c)(1). Specifically, petitioner asserts that she has shown that she received the
Tdap vaccine, which is set forth in the Table; received the vaccine in the United States;
sustained a SIRVA as described in the QAI within the time set forth in the Table;
suffered the residual effects of her injury for more than six months after vaccination; and
has not previously collected an award or settlement of a civil action for damages for
such vaccine-related injury.
Petitioner asserts that respondent has not met the burden required by
§ 13(a)(1)(B) to rebut petitioner’s proof establishing entitlement because respondent
has not filed any evidence to meet this burden. Petitioner asserts that she has
established that the Table criteria for SIRVA are met. In short, petitioner argues that
respondent bears the burden of proof of demonstrating the shoulder injury was caused
by the shingles vaccination rather than the Tdap vaccination, and that respondent has
not met this burden.
b. Respondent’s Arguments
Respondent argues that because the petition in this case was filed prior to
SIRVA being added to the Table, petitioner is not entitled to a presumption of causation
and must prove that the vaccine actually caused her SIRVA. Respondent’s December
7, 2018 Brief in Response to October 31, 2018 Scheduling Order (“Respondent’s
December 7, 2018 Brief), filed Dec. 7, 2018, at *2 (ECF No. 67). Respondent asserts
that petitioner must establish by preponderant evidence that the Tdap vaccination,
rather than the shingles vaccine, was the cause of her SIRVA. Id. at 2-3. Respondent
asserts that “there is no evidentiary basis for [the undersigned] to conclude that the
Tdap vaccine was more likely than the shingles vaccine to have caused petitioner’s
SIRVA, and indeed any such finding to that effect would constitute legal error.” Id. at 3.
Respondent acknowledges that petitioner could re-file her petition to allege a Table
SIRVA claim but asserts that because she has not done so, “her claim therefore must
be analyzed under the legal standards in effect on the date her petition was filed.” Id.,
at *2 n.2.
Respondent asserts that because the intramuscular administration of any
vaccine could potentially cause a SIRVA, it is reasonable to infer in this case that the
non-covered vaccination alone, in this case shingles, caused petitioner’s SIRVA.
Respondent’s Opposition to Petitioner’s Second Motion for Summary Judgment
(“Respondent’s Opposition to Second MSJ”), filed Dec. 13, 2018, at *2 (ECF No. 69).
10

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 11 of 28
Respondent cites Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986), for the
proposition that, in evaluating a summary judgment motion, all justifiable inferences
should be drawn in favor of the non-movant. Id. Respondent asserts that petitioner
cannot show that the covered vaccination more likely than not caused her SIRVA and
thus “there is a genuine dispute as to a material fact that precludes summary judgment
for petitioner.” Id.
Respondent declined to submit evidence concerning entitlement. Respondent’s
December 7, 2018 Brief at *1 n.1 (ECF No. 67) (“Respondent elects not to submit any
additional evidence at this time, because he is not the burdened party and because, as
explained herein, the record evidence currently fails to satisfy petitioner’s burden of
proof as a matter of law”) (emphasis added).
IV. Summary Judgment Standards for Adjudication and Analysis
Pursuant to Vaccine Rule 8(d), a special master may decide a case based on a
summary judgment motion. If a summary judgment motion is filed, Rule of the Court of
Federal Claims (“RCFC”) 56(a) applies and allows the court to decide a claim on
summary judgment “if the movant shows that there is no genuine dispute as to any
material fact and the movant is entitled to judgment as a matter of law.”
“The party moving for summary judgment ‘bears the burden of demonstrating
absence of all genuine issues of material fact.’” Jay v. Sec’y of Health and Human
Servs., 998 F.2d 979, 982 (Fed. Cir. 1993) (quoting SRI Int'l v. Matsushita Elec. Corp. of
Am., 775 F.2d 1107, 1116 (Fed.Cir.1985) (en banc)). If the evidence presented is
insufficient to permit a reasonable factfinder to find in favor of the nonmoving party,
there is no genuine issue of material fact. Jay, 998 F.2d at 982 (citing Anderson, 477
U.S. at 249). “The summary judgment inquiry in essence is whether the evidence
presents a sufficient disagreement of fact to require submission to the factfinder or
whether it is ‘so one-sided that one party must prevail as a matter of law.’” Id.
The existence of a dispute as to a legal issue does not preclude the entry of
summary judgment. See Howes v. Medical Components, Inc., 814 F.2d 638, 643 (Fed.
Cir. 1987) (in patent case, stating that claim construction is a question of law and “the
mere existence of a dispute as to that legal issue does not preclude summary
judgment”).
In the October 31, 2018 fact ruling, the undersigned resolved several disputed
factual issues, including the site of administration of petitioner’s October 19, 2015
vaccinations, the onset of her shoulder injury, and whether a lipoma on her back caused
her shoulder symptoms.
Respondent appears to assert that whether a non-covered vaccination, shingles,
caused petitioner’s injury is a disputed material fact that precludes summary judgment.
However, respondent concedes that “the record evidence establishes, at best, that the
Tdap vaccine and the shingles vaccine were both equally likely to have caused
11

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 12 of 28
petitioner’s SIRVA.” Respondent’s December 7, 2018 Brief at *1-2 (ECF No. 67)
(emphasis added).
Respondent has offered no proof to demonstrate that the non-covered shingles
vaccine was more likely than the Tdap vaccine to have caused petitioner’s SIRVA or
that the Tdap vaccine did not cause petitioner’s SIRVA. Thus, the evidence is
insufficient to permit a reasonable factfinder to find in respondent’s favor. Therefore,
under the Jay standard, there is no genuine issue of material fact in this case and
summary judgment is appropriate.
Moreover, with respect to the “fact” that respondent asserts is disputed, the
undersigned has made all factual findings that can be made on this issue based on the
evidence in the record, and the remaining issues pertain to the legal implications of the
facts that have been found.
All that remains to be resolved concerning entitlement in this case are the
following issues: whether petitioner’s case may be analyzed as a Table case or
petitioner must establish causation in fact; whether petitioner has established causation
under the appropriate standard; and how to analyze the effect of a potential alternative
cause and who bears the burden of proof on a potential alternative cause pursuant to
§ 13(a)(1)(B). There are no remaining issues of material fact. Thus, this case is
appropriate for resolution on summary judgment.7
The court previously informed the parties that on December 7, 2018, “the record
in this matter with regard to entitlement will close and a ruling or decision will issue
thereafter.” Scheduling Order, issued Oct. 31, 2018 (ECF No. 64). The parties have
had ample opportunity to submit evidence and arguments on the issue of entitlement.
The undersigned has fully considered the issues raised in Petitioner’s Second MSJ
[ECF Nos. 66, 66-1], Respondent’s Opposition to Second MSJ [ECF No. 69],
petitioner’s reply (“Petitioner’s Reply, Second MSJ”) [ECF No. 70], and Respondent’s
December 7, 2018 Brief [ECF No. 67]. For the reasons described below, the
undersigned finds that petitioner is entitled to compensation.
V. Legal Standard for Establishing Causation
In order to establish entitlement to compensation under the Vaccine Act, a
petitioner must demonstrate, by a preponderance of evidence, all matters required
under Section 11(c)(1). § 13(a)(1)(A). In determining whether a petitioner has done so,
the special master or court should consider the record as a whole. § 13(a)(1).
Petitioner’s allegations must be supported by medical records or by medical opinion. Id.
7 Even if summary judgment were not appropriate, this is a case where a motion for a ruling on the record
could have been filed and granted in petitioner’s favor. See Vaccine Rule 8(d) (allowing a special master
to decide a case on the basis of written submissions). The parties have fully briefed the disputed issues
concerning entitlement in the summary judgment motion papers and respondent’s December 7, 2018
brief. Thus, the undersigned determines that it is appropriate to determine entitlement.
12

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 13 of 28
In addition to requirements concerning the vaccination received, the duration and
severity of petitioner’s injury, and the lack of other award or settlement,8 a petitioner
must establish that she suffered an injury meeting the Table criteria, in which case
causation is presumed, or an injury shown to be caused-in-fact by the vaccination she
received. § 11(c)(1)(C). The most recent version of the Table, which can be found at
42 C.F.R. § 100.3, identifies the vaccines covered under the Program, the
corresponding injuries, and the time period in which the particular injuries must occur
after vaccination. § 14(a).
The injury alleged in this petition is a shoulder injury related to vaccine
administration (“SIRVA”). Petition (ECF No. 1) at *1-3. SIRVA was added to the
Vaccine Injury Table effective for petitions filed on or after March 21, 2017.
The petition in this case was filed on November 4, 2016, four months prior to the
effective date of the amendments adding SIRVA to the Table. If the petition in this case
had been filed on or after March 21, 2017, as it could have been under the lookback
provision in § 16(b), the parties agree that the revised Table would be applicable. See,
e.g., respondent’s statement that “[r]espondent acknowledges that petitioner could
dismiss the instant claim and re-file her petition to allege a Table SIRVA claim.
However, she has not done so, and her claim therefore must be analyzed under the
legal standards in effect on the date her petition was filed.” Respondent’s December 7,
2018 Brief at *2 n.2 (ECF No. 67).
Because this case was filed prior to the effective date of the Table amendments,
the parties dispute whether it may be analyzed as a Table case. In August 2017, the
parties debated this issue in their submissions for and against the first summary
judgment motion. This issue was also contested in respondent’s Rule 4(c) Report,
Respondent’s December 7, 2018 Brief, and the submissions for and against the second
summary judgment motion filed in December 2018.
Both parties agree that pursuant to Vaccine Act § 14(c)(4), any Table
modifications “shall apply only with respect to petitions for compensation under the
Program which are filed after the effective date of such regulation.” See Petitioner’s
First Motion for Summary Judgment, filed Aug. 28, 2017 (ECF No. 30-1), at *8;
Respondent’s Response to First Motion for Summary Judgment, filed Aug. 30, 2017
(ECF No. 31), at *13. However, they differ in their view as to how respondent has
implemented Table modifications in the past.
Petitioner argues that this case should be treated as a Table case. In the
Summary Judgment Motion filed on August 28, 2017 (ECF No. 30), petitioner asserted
that respondent had a long-standing policy of applying Table changes without reference
8 In summary, a petitioner must establish that she received a vaccine covered by the Program,
administered either in the United States and its territories or in another geographical area but qualifying
for a limited exception; suffered the residual effects of her injury for more than six months, died from her
injury, or underwent a surgical intervention during an inpatient hospitalization; and has not filed a civil suit
or collected an award or settlement for her injury. See § 11(c)(1)(A)(B)(D)(E).
13

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 14 of 28
to whether the petition was filed before or after the Table changes took effect.
Petitioner’s First Summary Judgment Motion, filed Aug. 28, 2017 (ECF No. 30-1).
Petitioner argued that respondent has conceded many cases in recent years that would
only have become Table injuries once the recent Table changes took effect in March
2017. Id. at *9-10.
In his response to the first summary judgment motion, respondent stated that
“had respondent determined that the facts of this case met the Table criteria,
respondent would have conceded entitlement to compensation.” Response to First
Motion for Summary Judgment, filed Aug. 30, 2017, at *14 (ECF No. 31). Yet in
Respondent’s December 7, 2018 Brief, respondent asserted that because this case was
filed before the Table amendments took effect, “petitioner may not take advantage of
the benefits of presumed causation afforded to Table injury claims.” Respondent’s
December 7, 2018 Brief at *2 (ECF No. 67). Respondent acknowledges that “petitioner
could dismiss the instant claim and re-file the petition to allege a Table SIRVA claim.
However, she has not done so, and her claim therefore must be analyzed under the
legal standards in effect on the date her petition was filed.” Id. at n.2.
Thus, respondent appears to have taken inconsistent positions, having earlier
stated that if this case met Table criteria respondent would have conceded the case, yet
now asserting that this case cannot be treated as a Table case because petitioner did
not dismiss this case and file a new petition.
While petitioner could have filed a new petition following the effective date of the
Table amendments adding SIRVA to the Table,9 she did not. Petitioner’s assertion that
respondent’s practice is to concede cases meeting Table criteria even if the petition was
filed prior to the Table revision is supported by respondent’s earlier assertion that “had
respondent determined that the facts of this case met the Table criteria, respondent
would have conceded entitlement to compensation.” Respondent’s Response to First
Motion for Summary Judgment, filed Aug. 30, 2017, at *14 (ECF No. 31).
Nevertheless, the undersigned cannot ignore the clear language of § 14(c)(4)
that Table modifications “shall apply only with respect to petitions for compensation”
filed after the effective date of the Table revisions. Thus, the undersigned proceeds to
analyze this case as if the March 21, 2017 revisions adding SIRVA to the Table do not
expressly govern entitlement in this case.
The undersigned finds that whether this is analyzed as a Table case or a
causation-in-fact case, petitioner has established a prima facie case and respondent
has not established that a factor unrelated to the Tdap vaccine caused petitioner’s
SIRVA. For purposes of this ruling, the undersigned treats this case as a causation-in-
9 Section 11(b)(2) states that “[o]nly one petition may be filed with respect to each administration of a
vaccine.” Nevertheless, § 16(b) creates an exception to this limitation in cases where the Table is revised
and “the effect of such revision is to permit an individual who was not, before such revision, eligible to
seek compensation under the Program, or to significantly increase the likelihood of obtaining such
compensation.”
14

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 15 of 28
fact case subject to the standard set forth in Althen v. Sec’y of Health and Human
Servs., 418 F.3d 1274, 1278 (Fed. Cir. 2005).
In a causation-in-fact case, the burden is on the petitioner to introduce evidence
demonstrating that the vaccination actually caused the injury in question. Althen, 418
F.3d at 1278; Hines v. Sec’y of Health and Human Servs., 940 F.2d 1518, 1525 (Fed.
Cir. 1991). The showing of “causation-in-fact” must satisfy the “preponderance of the
evidence” standard, the same standard ordinarily used in tort litigation. § 13(a)(1)(A);
see also Althen, 418 F.3d at 1279; Hines, 940 F.2d at 1525. Under that standard, the
petitioner must show that it is “more probable than not” that the vaccination was the
cause of the injury. Althen, 418 F.3d at 1279.
The petitioner need not show that the vaccination was the sole cause or even the
predominant cause of the injury or condition, but must demonstrate that the vaccination
was a legal cause by showing that the vaccine was at least a “substantial factor” in
causing the condition. Shyface v. Sec’y of Health and Human Servs., 165 F.3d 1344,
1352 (Fed. Cir. 1999). If petitioner makes this showing, petitioner has established that
the vaccine is a legal cause of the harm. Id.
In Althen, the Federal Circuit articulated a three-part test incorporating
requirements established in other decisions for demonstrating causation. The Althen
court explained this “causation-in-fact” standard as follows:
Concisely stated, Althen’s burden is to show by preponderant evidence that
the vaccination brought about her injury by providing: (1) a medical theory
causally connecting the vaccination and the injury; (2) a logical sequence
of cause and effect showing that the vaccination was the reason for the
injury; and (3) a showing of proximate temporal relationship between
vaccination and injury. If Althen satisfies this burden, she is “entitled to
recover unless the [government] shows, also by a preponderance of the
evidence, that the injury was in fact caused by factors unrelated to the
vaccine.
Althen, 418 F.3d at 1278 (citations omitted). In finding causation, a fact-finder may rely
upon “circumstantial evidence,” which the court found to be consistent with the “system
created by Congress, in which close calls regarding causation are resolved in favor of
injured claimants.” Id. at 1280.
Petitioner may establish a prima facie case that her injury was caused by a covered
vaccine by satisfying the Althen test. Deribeaux v. Sec’y of Health and Human Servs.,
717 F.3d 1363, 1367 (Fed. Cir. 2013). “Once a petitioner establishes her prima facie
case by satisfying the Althen test, the burden then shifts to the respondent to show by a
preponderance of the evidence that the injury is due to factors unrelated to the
administration of the vaccine. Id.
In determining whether a petitioner alleging a SIRVA has met the Althen criteria,
the undersigned considers the Qualifications and aids to interpretation (“QAI”) included
15

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 16 of 28
in the revised Table for SIRVA to be persuasive regarding the factors necessary to
demonstrate a logical sequence of cause and effect in a SIRVA case, even if the
petition was filed prior to the effective date of the Table modification.
Whether a petition alleging a SIRVA was filed before or after the effective date of
the Table modification has no impact on the scientific or medical understanding of the
injury or mechanism of injury. In either case, the same issues are relevant to assessing
causation. The Table criteria and QAI are the very criteria that the Secretary of Health
and Human Services has determined are relevant to causation in a SIRVA case. Thus,
the SIRVA Table criteria and QAI provide a framework for assessing causation in
SIRVA cases regardless of whether they are analyzed under the Table or the Althen
factors.
Therefore, the undersigned determines that in a case involving a SIRVA, the
Table criteria and QAI are relevant to an analysis of whether a vaccine caused a
SIRVA, regardless of whether the petition was filed before or after the date when the
modification adding SIRVA to the Table became effective. In a case filed after the
Table modification took effect, the analysis involves a straightforward determination of
whether the Table and QAI criteria are met. In a case filed before the Table
modification became effective, the analysis is slightly different but nevertheless involves
application of the Table and QAI criteria. In such a case, the undersigned determines
that the proper analysis is to apply Althen to determine whether a petitioner has proved
her injury was caused in fact by the vaccination in question, and to use the Table and
QAI as instructive in determining whether petitioner has met that burden.
VI. Analysis of Causation
Below, the undersigned first analyzes the three Althen prongs to determine
whether petitioner has established a prima facie case that a covered vaccine caused
her SIRVA. Next, because respondent asserts that a factor unrelated to the
administration of a covered vaccine caused petitioner’s injury, the undersigned analyzes
which party has the burden of proof with respect to the “factors unrelated” and whether
that burden of proof has been met.
For the reasons set forth below, the undersigned finds that petitioner has
established that the Tdap vaccine was a substantial factor in causing her SIRVA. Next,
the undersigned finds that pursuant to the Federal Circuit’s decision in Walther, the
burden of proof with respect to “factors unrelated” to the administration of a covered
vaccine is on respondent. Finally, the undersigned finds that respondent has not met
his burden to demonstrate that an unrelated factor caused petitioner’s injury. Thus, the
undersigned finds that petitioner has shown entitlement to compensation.
a. Petitioner’s Prima Facie Case
Petitioner may establish a prima facie case that her injury was caused by a covered
vaccine by satisfying the Althen test. Deribeaux v. Sec’y of Health and Human Servs.,
16

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 17 of 28
717 F.3d 1363, 1367 (Fed. Cir. 2013). “Once a petitioner establishes her prima facie
case by satisfying the Althen test, the burden then shifts to the respondent to show by a
preponderance of the evidence that the injury is due to factors unrelated to the
administration of the vaccine.” Id. Therefore, the first step is to analyze whether petitioner
has established the Althen prongs. For the reasons set forth below, the undersigned finds
that she has.
i. Althen Prong One
Under Althen Prong One, there must be preponderant evidence of a medical
theory causally connecting petitioner’s vaccination to her injury. In satisfaction of Althen
Prong One, the undersigned takes judicial notice of the fact that respondent has added
SIRVA to the Vaccine Injury Table for the influenza vaccine. See National Vaccine
Injury Compensation Program: Revisions to the Vaccine Injury Table, 80 Fed. Reg.
45132, Notice of Proposed Rulemaking, July 29, 2015 (citing Atanasoff et al., Court Ex.
I); see also Doe 21 v. Sec’y of Health and Human Servs., 88 Fed. Cl. 178 (July 30,
2009), rev’d on other grounds, 527 Fed. Appx. 875 (Fed. Cir. 2013) (holding that
recognition of a link between vaccine and injury on the Vaccine Injury Table supports
petitioner’s burden under Althen Prong One).
In adding SIRVA to the Table, the Secretary of Health and Human Services
determined that, for vaccines listing SIRVA as a Table injury,10 there is a sufficient
causal connection between the administration of such vaccines and SIRVA to warrant
adding SIRVA to the Table. In other words, the Secretary has determined that
intramuscular administration of certain vaccines can cause SIRVA.
Further, the literature and medical records filed in this case provide preponderant
evidence of a medical causal theory. Atanasoff and Bodor set forth a proposed
mechanism of injury, “the unintentional injection of antigenic material into synovial
tissues resulting in an immune-mediated inflammatory reaction.” Atanasoff, Court
Exhibit I at 1-3 (citing Bodor, Court Exhibit II). This occurs when the vaccine is “injected
into the subdeltoid bursa . . . causing a robust local inflammatory and immune
response” which leads to “bursitis, tendinitis, and inflammation of the shoulder capsule.”
Id. at 2.
Moreover, two of petitioner’s physicians opined that petitioner had a left shoulder
injury due to the October 19, 2015 vaccines administered in her left deltoid. On
February 2, 2016, Dr. Nicholas Leroy of the Center for Progressive Health examined
petitioner due to left shoulder pain following tetanus and shingles vaccines in her left
deltoid in October. Pet. Ex. 2 at 3-4. Dr. Leroy assessed petitioner as having left “rot.
[rotator] cuff syndrome 2° [secondary] to Oct 2015 vaccine shots [in left] deltoid.” Id. at
3.
10 The undersigned notes that the shingles vaccine is not listed in the Table and thus SIRVA is not a
Table injury for the shingles vaccine, while SIRVA is a Table injury for Tdap. However, the undersigned
does not view this difference as dispositive.
17

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 18 of 28
In addition, after examining petitioner and ruling out a back lipoma as a cause of
petitioner’s left shoulder condition, Dr. Ellis Nam assessed her with “Left shoulder pain,
s/p [status post] tetanus/shingles injection on 10/2015.” Pet. Ex. 24 at 3. Dr. Nam
described petitioner’s left shoulder condition as one that “she developed as a result of
the tetanus/shingles shot in her left shoulder on October, 2015.” Pet. Ex. 24 at 2.
Thus, petitioner has met Althen Prong One.
ii. Althen Prong Two
Under Althen Prong Two, petitioner must demonstrate a logical sequence of
cause and effect showing that the vaccination was the reason for the injury. The
undersigned determines that the SIRVA QAI criteria set forth a logical sequence of
cause and effect and that by establishing that the QAI criteria are met, a petitioner may
establish that Althen Prong Two has been met.
The criteria under the QAI for SIRVA are as follows:
A vaccine recipient shall be considered to have suffered SIRVA if such
recipient manifests all of the following: (i) No history of pain, inflammation
or dysfunction of the affected shoulder prior to intramuscular vaccine
administration that would explain the alleged signs, symptoms, examination
findings, and/or diagnostic studies occurring after vaccine injection; (ii) Pain
occurs within the specified time-frame; (iii) Pain and reduced range of
motion are limited to the shoulder in which the intramuscular vaccine was
administered; and (iv) No other condition or abnormality is present that
would explain the patient’s symptoms (e.g. NCS/EMG or clinical evidence
of radiculopathy, brachial neuritis, mononeuropathies, or any other
neuropathy).
82 Fed. Reg. 6303 (Qualifications and Aids to Interpretation for SIRVA).
In light of the factual history described above, the undersigned finds that all four
of the criteria listed in the QAI for SIRVA are satisfied by preponderant evidence in this
case.
1. No history of pain, inflammation or dysfunction of the
affected shoulder prior to intramuscular vaccine
administration that would explain the alleged signs,
symptoms, examination findings, and/or diagnostic
studies occurring after vaccine injection
Upon the undersigned’s review, nothing in petitioner’s prior medical history
suggests any relevant history of pain, inflammation or dysfunction of petitioner’s left
shoulder.
18

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 19 of 28
2. Pain occurs within the specified time-frame
The question of when petitioner’s shoulder pain first manifested is one of the
bases for respondent’s recommendation against compensation in this case. In his Rule
4(c) Report, respondent argued that the records did not establish that the onset of pain
occurred within 48 hours of vaccination. Respondent’s Rule 4(c) Report at 7 n.2. At the
hearing and in the subsequent October 31, 2018 fact ruling, however, the undersigned
resolved this factual dispute. The undersigned found that the onset of petitioner’s injury
occurred within 48 hours. This finding is supported by several pieces of evidence.
On February 18, 2016, Dr. Perrott documented “injections in left deltoid since
October” and “since then” pain in the left shoulder region. Pet. Ex. 14 at 3. On
December 22, 2015, Dr. Noriega documented that petitioner reported “left arm pain after
two shots,” Pet. Ex. 3 at 42. Dr. Townsend Scott also documented left shoulder pain
that began after receiving two immunizations in the left arm. Pet. Ex. 3 at 326. The
Center for Progressive Health documented that petitioner had “left shoulder pain
following tetanus and shingles shots in left deltoid” in October. Pet. Ex. 2 at 3-4.
At the hearing, petitioner testified that she experienced immediate soreness
following vaccination. Tr. 11. She testified that she repeatedly called the clinic to report
the pain and was told to give it some time to go away. Tr. 11-12. She testified that on
the day after vaccination she had limited movement in her arm and was still in pain. Tr.
14.
The undersigned finds that the preponderance of the evidence establishes that
the onset of petitioner’s pain was within 48 hours after vaccination.
3. Pain and reduced range of motion are limited to the
shoulder in which the intramuscular vaccine was
administered
The undersigned finds no evidence that petitioner’s pain and reduced range of
motion extended beyond her left shoulder. Petitioner consistently reported pain in her
left shoulder. While a physician theorized that a lipoma on her back could be related,
another physician opined that the back lipoma was unrelated to petitioner’s shoulder
pain. Moreover, petitioner testified that the lipoma has been on her back for 15 years
and during that time has remained asymptomatic. The undersigned finds that the
preponderance of the evidence establishes that petitioner’s pain and reduced range of
motion were limited to the shoulder in which the intramuscular vaccine was
administered.
4. No other condition or abnormality is present that would
explain the patient’s symptoms (e.g. NCS/EMG or
19

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 20 of 28
clinical evidence of radiculopathy, brachial neuritis,
mononeuropathies, or any other neuropathy)
The undersigned also finds no evidence of any condition or abnormality that
would otherwise explain her symptoms. As noted above, the preponderance of the
evidence establishes that petitioner’s back lipoma does not explain petitioner’s
symptoms.
5. Additional considerations
Moreover, separate and apart from the specific requirements of the QAI, as
noted above, there are additional considerations that weigh in favor of finding that
petitioner has satisfied the second prong of Althen.
First, two of petitioner’s treating physicians opined that petitioner’s shoulder
condition was vaccine-caused.11 See, e.g. Pet. Ex. 2 at 3; Pet. Ex. 24 at 1. “[T]reating
physicians are likely to be in the best position to determine whether ‘a logical sequence
of cause and effect show [s] that the vaccination was the reason for the injury.’ ”
Capizzano v. Sec'y of Health & Human Servs., 440 F.3d 1317, 1326 (Fed. Cir. 2006)
(quoting Althen, 418 F.3d at 1280).
Second, the Federal Circuit’s adoption of the Restatement (Second) of Torts and
analysis in Shyface supports a finding that the Tdap vaccine was a substantial factor in
causing petitioner’s injury and thus the second Althen prong has been established.
In Shyface, the Federal Circuit adopted the Restatement (Second) of Torts and
ruled that “an action is the ‘legal cause’ of harm if that action is a ‘substantial factor’ in
bringing about the harm, and [the] harm would not have occurred but for the action.”
Shyface, 165 F.3d at 1352. In that case, petitioner’s expert testified that an infant’s
death was caused by a high fever, which resulted from a combination of administration
of a covered vaccine and an infection. Shyface, 165 F.3d at 1345-46. However,
petitioner’s expert could not determine which of these two factors was more
responsible. Id. Thus, the special master ruled against the petitioners, finding that
“[p]etitioners evidence of a vaccine-related cause stands possibly in equipoise, but no
better.” Id. at 1347 (quoting special master’s decision) (emphasis added).
The Federal Circuit determined that evidence that the combination of the factors
caused the death was sufficient to establish entitlement to compensation for a vaccine
injury even if the vaccine was not the predominant cause, as long as it was a substantial
factor. In determining whether it was a substantial factor, the Federal Circuit looked to
the Restatement (Second) of Torts § 432(2), which states:
If two forces are actively operating, one because of the
actor’s negligence, the other not because of any misconduct
on his part, and each of itself is sufficient to bring about harm
11 While a treating physician also considered petitioner’s back lipoma as a possible cause, Dr. Nam
opined that the lipoma had no effect on petitioner’s shoulder condition, Pet. Ex. 24, and the undersigned
has already ruled that the lipoma did not cause petitioner’s shoulder symptoms.
20

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 21 of 28
to another, the actor’s negligence may be found to be a
substantial factor in bringing it about.
Restatement (Second) of Torts § 432(2) (quoted in Shyface, 165 F.3d at 1352)
(emphasis added).
Applying the Restatement § 432(2) here, respondent agrees that based on the
facts in this case “it is impossible to attribute causation to one vaccine or the other.”
Respondent’s December 7, 2018 Brief at *2-3 (ECF No. 67). In addition, the covered
vaccine, Tdap, itself was sufficient to bring about harm. Thus, under these
circumstances, the undersigned finds that the Tdap vaccine was a substantial factor in
causing petitioner’s injury.
Thus, for all of the above reasons, the undersigned finds that petitioner has
satisfied Althen Prong Two.
iii. Althen Prong Three
Under Althen Prong Three, there must be a proximate temporal relationship
between vaccination and injury. In this case, both parties agree that the relevant
medically accepted timeframe for onset of a SIRVA injury is within 48 hours of
vaccination. As noted above, the undersigned found that the preponderance of the
evidence supports a finding that the onset of petitioner’s SIRVA occurred within 48
hours of vaccination. Thus, petitioner has satisfied Althen Prong Three.
Because petitioner has satisfied all three Althen prongs and thus established a
prima facie case, the burden then shifts to respondent to prove, by a preponderance of
the evidence, that petitioner’s injury was caused by factors unrelated to the
administration of the Tdap vaccine.
b. Factors Unrelated to Vaccination
In determining entitlement to compensation, Vaccine Act § 13(a)(1) provides:
Compensation shall be awarded under the Program to a
petitioner if the special master or court finds on the record as
a whole
(A) that the petitioner has demonstrated by a
preponderance of the evidence the matters required in
the petition by section 300aa-11(c)(1) of this title; and
(B) that there is not a preponderance of the
evidence that the illness, disability, injury, condition, or
death described in the petition is due to factors
unrelated to the administration of the vaccine
described in the petition.
Vaccine Act § 13(a)(1) (emphasis added).
21

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 22 of 28
Respondent asserts that two factors unrelated to the covered Tdap vaccination
may have contributed to petitioner’s injury. First, respondent asserts that petitioner’s
back lipoma may have contributed to her injury. As noted above, the undersigned has
previously found that the preponderance of the evidence does not support this
contention. This finding is supported by Dr. Nam’s opinion that the lipoma was
unrelated to petitioner’s shoulder condition as well as petitioner’s testimony, which the
undersigned found credible.
Second, respondent asserts that on the date of vaccination, petitioner received
two vaccines in her injured arm, a Tdap vaccine and a shingles vaccine. As determined
above, by establishing the Althen factors are met, petitioner has established a prima
facie case that the Tdap vaccine caused her SIRVA. For the purpose of fully addressing
respondent’s arguments, the undersigned analyzes this issue as a “factor unrelated to
the administration of the vaccine” as well.
With limited exceptions related to polio that are not applicable here, to be entitled
to compensation a petition must assert an illness or injury caused by a vaccine set forth
in the Vaccine Injury Table, 42 C.F.R. §100.3. Vaccine Act § 11(c)(1). The Tdap
vaccine is listed in the Table, while the shingles vaccine is not. See, e.g., Duke v. Sec’y
of Health and Human Servs., No. 15-473V, 2015 WL 4124547, at *2 (Fed. Cl. Spec.
Mstr. June 12, 2015) (“The shingles vaccine is not listed on the Table and is therefore
not covered by the Program” and noting the dismissal of previous petitions seeking
compensation for injuries from the shingles vaccine). Respondent argues that petitioner
has not established that the covered Tdap vaccine, rather than the non-covered
shingles vaccine, caused her injury.
The undersigned previously made a fact finding that petitioner received both the
Tdap and shingles vaccinations in her injured left arm. In her petition, petitioner listed
all three vaccines received on October 19, 2015. Petition, filed Nov. 4, 2016, at ¶ 3
(ECF No. 1). However, in her second summary judgment motion, petitioner asserts
entitlement to compensation based on the tetanus, or Tdap, vaccine. Petitioner’s
Second MSJ, filed Dec. 4, 2018, at 5 (ECF No. 66-1). In addition, the shingles vaccine
is not a covered vaccine and petitioner asserts that the flu vaccine was administered
into her right arm. Thus, the undersigned analyzes petitioner’s claim as asserting
entitlement to compensation based on the Tdap vaccine, which is listed in the Table.
Above, the undersigned determined that petitioner had shown by a preponderance of
the evidence that the Tdap vaccine caused her SIRVA and thus made the showing
required under § 13(a)(1)(A) to establish a prima facie case.
Respondent asserts that petitioner testified that the vaccines were administered
almost at the same time and that she felt tingling only after both were administered.
Respondent’s December 7, 2018 Brief at *2-3 (ECF No. 67). Thus, respondent asserts
that “at best, the evidence is in equipoise with respect to the Tdap and shingles
vaccines as the cause of petitioner’s SIRVA.” Id. at *3. Respondent argues that it is
petitioner’s burden to demonstrate that the Tdap vaccine was more likely to cause the
22

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 23 of 28
injury than the shingles vaccine and that because she cannot meet the burden, her
claim must fail.
As discussed above, the undersigned determines that petitioner has met her
burden to demonstrate that the Tdap vaccine was a legal cause of her SIRVA and thus
has established a prima facie case.
Citing the Federal Circuit’s decision in Walther v. Sec’y of Health and Human
Servs., 485 F.3d 1146 (Fed. Cir. 2007), petitioner asserts that under § 13(a)(1)(B), it is
respondent’s burden to prove that the injury petitioner asserts is vaccine-related was
actually caused by a factor unrelated to the vaccination. In other words, petitioner
asserts that it is respondent’s burden to prove that the non-covered shingles vaccine
caused the injury and that, unless he is able to do so, petitioner should prevail.
Walther is strikingly similar in that it also involves the question whether
petitioner’s injury was caused by a covered or non-covered vaccine. In Walther, the
petitioner received four vaccines – tetanus-diphtheria (“Td”), yellow fever, and
meningitis on July 31, 1997, and rabies on August 6, 1997. Of these four vaccines, only
the Td vaccine was included in the Vaccine Injury Table. On August 7 and 8 she began
experiencing trembling, weakness, and fatigue. She was ultimately diagnosed with
post-vaccinal acute disseminated encephalomyelitis (“ADEM”). Petitioner’s expert
testified that it was more likely than not that her ADEM was caused by the Td vaccine
and that, for reasons specific to each vaccine, the other vaccines she received were
unlikely to have caused her illness. The government primarily argued that petitioner did
not suffer from ADEM, but also contended that even if she suffered from ADEM, it was
not caused by the Td vaccine.
The special master in Walther dismissed the petition, finding that Walther had not
carried her burden to prove that her illness was caused by the Td vaccine, in part
because she had not presented proof eliminating other potential causes for her injury.
Walther, 485 F.3d at 1147.12 The petitioner unsuccessfully sought review in the Court
of Federal Claims. On appeal at the Federal Circuit, petitioner argued that the special
master “applied an incorrect standard requiring her to eliminate other potential causes in
order to establish a prima facie case of causation.” Id. at 1148. The Federal Circuit
ruled that while petitioner may use evidence eliminating other potential causes to help
carry the burden on causation, petitioner does not bear the burden of eliminating
alternative independent potential causes. Id. at 1150-52. The court ruled that once
petitioner has established a prima facie case, “the government bears the burden of
establishing alternative causation by a preponderance of the evidence.” Id. at 1151.
The Federal Circuit noted that § 13(a)(1)(A) by its terms places the burden of
proof on petitioner, while § 13(a)(1)(B) is silent with respect to burden of proof. Walther,
12 The special master’s decision in Walther was issued on July 29, 2005, the same day that the Federal
Circuit issued its decision in Althen. The special master’s Walther decision thus had applied a different
causation standard than that set forth in Althen.
23

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 24 of 28
485 F.3d at 1150-51. The court stated that a “plain reading of the statutory text [of
subsection (B)] more naturally places the burden on the government to establish that
there is an alternative cause by a preponderance of the evidence.” Id. at 1150. The
court reasoned that assigning the burden of proof under subsection B to plaintiff “would
essentially write § 300aa-13(a)(1)(B) out of the statute.” Id.
The Walther court then looked to the Restatement (Second) of Torts, explaining
that for purposes of causation a petitioner is treated as the equivalent of a tort plaintiff
and the government as the equivalent of a tort defendant. The court noted that the
Restatement (Second) of Torts § 433B(3) provided that in cases involving multiple
independent potential causes, where harm has been caused by only one of them but
there is uncertainty as to which one, “the burden is upon each such actor [tort
defendant, or respondent in this case] to prove that he has not caused the harm.”
Walther, 485 F.3d at 1151 (quoting Restatement (Second) of Torts § 433B(3) (1965)).
Applying this to the Vaccine Act, the court stated that “the petitioner generally
has the burden on causation, but when there are multiple independent potential causes,
the government has the burden to prove that the covered vaccine did not cause the
harm.” Id. The court determined that “in both Table and off-Table [causation-in-fact, or
Althen, cases] cases the government bears the burden of establishing alternative
causation by a preponderance of the evidence once the petitioner has established a
prima facie case.”13 Id.
Thus, in a case similar to this case, in that both involve the question of causation
when a petitioner received multiple vaccines close in time, the Federal Circuit has
addressed the very question at issue in this case and determined that the burden of
proof with respect to alternative causes is on respondent.
In another case, the Federal Circuit cited Walther and stated that “[o]nce the
petitioner has established a prima facie case for entitlement to compensation and thus
met her burden to prove causation-in-fact, the burden shifts to the government to prove
‘[by] a preponderance of the evidence that [petitioner’s injury] is due to factors unrelated
to the administration of the vaccine described in the petition . . . . So long as the
13 This rationale has been followed by Special Masters in other cases. See, e.g., Heinzelman v. Sec’y of
Health and Human Servs., No. 2007-01V, 2008 WL 5479123, at *17 (Fed. Cl. Spec. Mstr. Dec. 11, 2008)
(concluding that petitioner’s “burden of proving ‘a logical sequence of cause and effect showing that the
vaccination was the reason for the injury’ does not include the obligation to negate possible alternative
causes” for her injury), mot. for rev. denied, 98 Fed. Cl. 808 (2011), aff’d on other grounds, 681 F.3d 1374
(Fed. Cir. 2012); Al-Uffi v. Sec’y of Health and Human Servs., No. 2013-956V, 2017 WL 1713113, at *19
(Fed. Cl. Spec. Mstr. Feb. 22, 2017) (“Because I find that Petitioner has established her prima facie case
by a preponderance of the evidence, the burden now shifts to Respondent to prove by a preponderance
of the evidence an alternative, unrelated cause” for petitioner’s condition) (citing Heinzelman); Deribeaux
v. Sec’y of Health and Human Servs., No. 2005-306V, 2011 WL 6935504, at *33 (Fed. Cl. Spec. Mstr.
Dec. 9, 2011) (assigning to respondent burden of proving that a factor unrelated to the vaccination
caused the injury pursuant to § 13(a)(1)(B)), mot. for rev. denied, 105 Fed. Cl. 583 (2012), aff’d, 717 F.3d
1363 (Fed. Cir. 2013).
24

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 25 of 28
petitioner has satisfied all three prongs of the Althen test, she bears no burden to rule
out possible alternative causes.” de Bazan v. Sec’y of Health and Human Servs., 539
F. 3d 1347, 1352 (Fed. Cir. 2008). “Once causation is established, the petitioner is
entitled to compensation unless the government can show by a preponderance of the
evidence that the injury is due to factors unrelated to the vaccine, i.e., an alternative
cause.” Porter v. Sec’y of Health and Human Servs., 663 F.3d 1242, 1249 (Fed. Cir.
2011).
Pursuant to the reasoning set forth in Walther, the tort defendant, or respondent
here, has the burden of proving that the non-covered vaccine, rather than the covered
vaccine, caused petitioner’s injury. Respondent has offered no evidence, other than the
fact that petitioner received a non-covered vaccine, to meet this burden.
Respondent asserts that the evidence as to which vaccine – Tdap or shingles –
caused petitioner’s SIRVA is, at best, in equipoise. There is evidence showing that
each vaccine was administered, but no evidence showing that either was more likely
than the other to have caused petitioner’s SIRVA. However, the analysis is not
either/or, as respondent suggests. Instead, the first inquiry is whether petitioner has
established a prima facie case that the Tdap caused her injury; the undersigned has
found that she has. The next inquiry is whether respondent has established by a
preponderance of the evidence that a factor unrelated to the Tdap caused petitioner’s
injury; the undersigned finds that he has not.
Respondent argues that a more recent Federal Circuit case, Stone v. Sec’y of
Health and Human Servs., 676 F.3d 1373, 1380 (Fed. Cir. 2012), “has limited the
approach articulated in Walther, which presumably allows the special masters to ignore
relevant evidence in the record when determining whether petitioners have met their
burden of proving vaccine-causation by a preponderance of the evidence.”
Respondent’s December 7, 2018 Brief at *2 (ECF No. 67).
The undersigned disagrees with respondent’s characterization of Walther.
Walther does not permit a special master to ignore evidence. Rather, Walther
addressed the issue of burden of proof on alternative causes.
With respect to Stone, the court in that case agreed that with “factors unrelated”
evidence, “a special master may not require the petitioner to shoulder the burden of
eliminating all possible alternative causes in order to establish a prima facie case.”
Stone, 676 F.3d at 1380 (emphasis added). Nevertheless, in Stone, the Federal Circuit
also stated that prior decisions support “the commonsense proposition that evidence of
other possible sources of injury can be relevant not only to the ‘factors unrelated’
defense, but also to whether a prima facie showing has been made that the vaccine
was a substantial factor in causing the injury in question.” Id. at 1379-80. The court
further stated that “in some cases a sensible assessment of causation cannot be made
while ignoring the elephant in the room – the presence of compelling evidence of a
different cause for the injury in question.” Id. at 1380.
25

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 26 of 28
The undersigned notes that in Walther, the alternative causes asserted by
respondent were four non-covered vaccines that petitioner received close in time to the
sole covered vaccine she received. Respondent’s position was that each of the non-
covered vaccines represented a biologically plausible explanation for her condition. In
contrast, in Stone, the asserted alternative cause was a genetic mutation that
respondent’s expert, who the special master found persuasive, testified was the sole
cause of petitioner’s illness. Thus, one distinction between these cases is that Walther
deals with a situation where, as in this case, respondent is raising the simple fact of a
non-covered vaccination as an alternative cause, whereas in Stone, respondent also
presented persuasive expert testimony as to a genetic etiology.
In a case where a petitioner has received multiple vaccines, some listed in the
Table and some not listed in the Table, in the same arm or other site, and is injured, it is
somewhat difficult to reconcile the approaches of Walther and Stone. In such cases, as
in this case, there may be little or no proof as to which vaccine or vaccines caused the
injury. In such circumstances, the determination as to who has the burden of proof with
respect to alternative causation may be dispositive.
One cohesive reading of Walther and Stone is that Walther applies in a situation
where respondent simply identifies a possible alternative cause with nothing more,
whereas Stone is relevant in a case where respondent presents an alternative cause
and evidence that the finder of fact finds persuasive enough to defeat petitioner’s prima
facie case. This reading was suggested in Heinzelman v. Sec’y of Health and Human
Servs., No. 07-01V, 2008 WL 5479123 (Fed. Cl. Spec. Mstr. Dec. 11, 2008), mot. for
rev. denied, 98 Fed. Cl. 808 (2011), aff’d on other grounds, 681 F.3d 1374 (Fed. Cir.
2012) (“Assuming that the Federal Circuit actually created a distinction between
situations in which the government challenged the persuasive value of petitioner’s
evidence on a particular prong and situations in which the government put forth a
particular agent as the cause of petitioner’s injury, then the distinction is important”).
Applying this reading to the facts of this case, Walther would govern because
respondent has offered no evidence at all, much less persuasive evidence, to
demonstrate that the non-covered shingles vaccine is more likely the cause of
petitioner’s injury than the covered Tdap vaccine. The undersigned interprets Walther
as supporting a ruling in favor of petitioner if petitioner establishes a prima facie case
and respondent does not establish by preponderant evidence that the injury was caused
by an unrelated factor.
Therefore, the undersigned determines that petitioner has established a prima
facie case that her SIRVA was caused by her Tdap vaccination. The undersigned
further finds that respondent has not met his burden of showing that the non-covered
shingles vaccine, rather than the covered Tdap vaccine, caused petitioner’s SIRVA.
See Suffolk Tech., LLC v. AOL Inc., 753 F.3d 1358, 1367 (Fed. Cir. 2014) (affirming
grant of summary judgment and placing on non-moving party the burden of presenting
26

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 27 of 28
evidence to undermine moving party’s showing that there are no genuine issues of
material fact).
Respondent argues that “it would be error for the Chief Special Master to ignore
the fact that petitioner received an uncovered shingles vaccine in the same arm, and at
the same time, as the covered Tdap vaccine when deciding whether petitioner has
shown that the Tdap vaccine is the more likely cause of her SIRVA” (ECF No. 67 at *5).
Respondent is mistaken.
First, the undersigned need not decide that the Tdap vaccine is the more likely
cause of petitioner’s SIRVA. The undersigned finds that petitioner has established a
prima facie case that a covered vaccine, Tdap, caused her SIRVA. Pursuant to
Walther, once petitioner has established a prima facie case, the burden shifts to
respondent to demonstrate that an unrelated factor caused the injury, and respondent
has offered no proof to meet this burden.
Second, the undersigned has not ignored that petitioner received a non-covered
shingles vaccine in the same arm as she received her Tdap vaccine. The undersigned
made this fact finding both at the end of the fact hearing and in a subsequent written
fact ruling. However, respondent has the burden to prove that the shingles vaccine
rather than the Tdap vaccine caused petitioner’s SIRVA, and respondent has not
offered any proof beyond mere administration of a non-covered vaccine and thus has
not met his burden.
Respondent asserts in a footnote that petitioner initially attributed her injury to the
shingles vaccine. Respondent’s Response to October 31, 2018 Scheduling Order, filed
Dec. 7, 2018, at *3 n.3 (ECF No. 67). Petitioner’s medical records indicate in some
notes that her pain began after a shingles vaccination and in other records that it began
after receiving shingles and tetanus, or Tdap, vaccines, or simply after two
immunizations, in her left arm. These statements are not inconsistent with each other
and would not support a finding that petitioner attributed her injury solely to the shingles
vaccine. Petitioner testified that she mentioned all three vaccines that she received to
her medical providers. The undersigned found petitioner to be a credible witness and
finds that the medical records are not inconsistent with petitioner’s testimony.
In this case, whether analyzed as a Table case or as a causation-in-fact case,
petitioner has established a prime facie case that a covered vaccine, Tdap, caused her
SIRVA. Respondent has not established that a factor unrelated to the Tdap vaccine,
either a back lipoma or a shingles vaccine, caused petitioner’s injury. The issue of
causation in this case is a close one. Keeping in mind that “close calls regarding
causation are resolved in favor of injured claimants,” Althen, 418 F.3d at 1280, the
undersigned determines that petitioner is entitled to compensation.
27

Case 1:16-vv-01458-UNJ Document 78 Filed 08/20/19 Page 28 of 28
VII. Conclusion
Thus, for all the foregoing reasons, the undersigned finds that petitioner is
entitled to compensation. Accordingly, the undersigned GRANTS petitioner’s motion
for summary judgment (ECF No. 66) and rules that petitioner is entitled to
compensation.
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
28

================================================================================
DOCUMENT 3: USCOURTS-cofc-1_16-vv-01458-3
Date issued/filed: 2019-11-15
Pages: 15
Docket text: PUBLIC DECISION (Originally filed: 08/23/2019) regarding 79 DECISION of Special Master Signed by Special Master Nora Beth Dorsey. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 1 of 15
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1458V
Filed: August 23, 2019
UNPUBLISHED
DENISE GORING,
Petitioner,
Special Processing Unit (SPU);
v.
Decision Awarding Damages; Pain
and Suffering; Tetanus Diphtheria
SECRETARY OF HEALTH AND
acellular Pertussis (Tdap) Vaccine;
HUMAN SERVICES,
Shoulder Injury Related to Vaccine
Administration (SIRVA)
Respondent.
Isaiah Richard Kalinowski, Maglio Christopher & Toale, PA, Washington, DC, for
petitioner.
Voris Edward Johnson, U.S. Department of Justice, Washington, DC, for respondent.
DECISION AWARDING DAMAGES1
Dorsey, Chief Special Master:
On November 4, 2016, petitioner filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to a
tetanus, diptheria, acellular pertussis (“Tdap”) vaccination she received on October 19,
2015.3 Petition at 1. The case was assigned to the Special Processing Unit of the
Office of Special Masters.
1 The undersigned intends to post this decision on the United States Court of Federal Claims' website.
This means the decision will be available to anyone with access to the internet. In accordance with
Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the
undersigned agrees that the identified material fits within this definition, the undersigned will redact such
material from public access. Because this unpublished decision contains a reasoned explanation for the
action in this case, undersigned is required to post it on the United States Court of Federal Claims'
website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal
Management and Promotion of Electronic Government Services).
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).
3 Petitioner received three vaccinations on October 19, 2015: Tdap, shingles, and influenza. Petitioner’s
exhibit (“Ex.”) 1 at 1.

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 2 of 15
For the reasons described below, the undersigned finds that petitioner is entitled
to an award of damages in the amount $75,200.00, representing compensation in the
amount of $75,000.00 for actual pain and suffering and $200.00 for past
unreimbursable expenses.
I. Relevant Procedural History4
Petitioner filed a petition for compensation for a shoulder injury related to vaccine
administration (“SIRVA”). (ECF No. 1). Respondent submitted a Rule 4(c) report on
August 10, 2017 asserting that petitioner had not established entitlement to
compensation due to an inadequate onset period for a SIRVA injury, uncertainty of the
vaccination site, and an alternate cause for petitioner’s shoulder injury. (ECF No. 29).
The undersigned held a fact hearing on September 18, 2018 with petitioner as
the sole witness. Goring v. Sec’y of Health & Human Serv., No. 16-1458V, 2018 WL
6539219, *2 (Fed. Cl. Spec. Mstr. Oct. 31, 2018). The undersigned found that
petitioner’s Tdap and shingles vaccines were administered to her left arm and the onset
of petitioner’s left shoulder injuries occurred within 48 hours of her October 19, 2015
vaccinations. Id at *1. The undersigned further ruled that a lipoma on petitioner’s back
was not a condition that explained her left shoulder symptoms. Id.
On May 6, 2019, the undersigned determined that petitioner was entitled to
compensation since she established that she suffered a shoulder injury caused by a
covered vaccine and respondent did not show that unrelated factors caused her injury.
Ruling on Entitlement at 2 (ECF No 78). On May 7, 2019, the parties were ordered to
discuss the appropriate amount of compensation in this case. (ECF No. 72).
Petitioner filed a joint status report on June 6, 2019 indicating the parties were
unable to agree on the amount of damages. (ECF No. 73). On June 27, 2019, the
undersigned ordered each party to file briefs to be considered in a decision awarding
compensation. (ECF No. 74).
The parties have filed their respective briefs and this case is now ripe for a
determination regarding an award of damages. (ECF Nos. 76, 77).
II. Relevant Medical History
Petitioner received three vaccines on October 19, 2015 including a Tdap vaccine
in her left shoulder. Ex. 1 at 1, Goring, 2018 WL 6539219 at *3. Petitioner’s prior
medical history does not include any mention of left shoulder problems and is not
otherwise relevant to her claim.
4 The undersigned adopts the comprehensive procedural history set forth in the Ruling on Entitlement
issued on May 6, 2019. (ECF No. 78).
2

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 3 of 15
Although petitioner asserted in an affidavit that she experienced painful
symptoms almost immediately, she was not seen by a medical provider for the pain until
December 22, 2015 when she presented to her primary care physician, Karen Noriega,
M.D. at Mercy Hospital. Ex. 3 at 42. Petitioner complained to Dr. Noriega of left arm
pain after receiving vaccinations two months ago, stating that the “pain is worsening
where she cannot lift her left arm over her head.” Id. Petitioner described an “aching”
pain and rated it at 6 on a pain scale of 1 to 10. Id. at 49. Dr. Noriega examined
petitioner and found she had decreased range of motion (“ROM”) in her left shoulder
and tenderness to deep palpation. Id. at 45. Dr. Noriega diagnosed her with left arm
pain and ordered a CT scan of petitioner’s left shoulder. Id.
On January 19, 2016, petitioner presented to the emergency room (“ER”) at
Mercy Hospital and Medical Center with a chief complaint of left arm pain. Ex. 3 at 278.
She described significant left shoulder pain and limited range of motion that started
when she received a vaccination in October 2015. Id. at 298. It was noted in the record
that she was previously seen for left shoulder symptoms. Id. At the prior visit, a CT
was ordered but not completed due to insurance issues. Id.
On examination at the ER, the internal and external rotation of petitioner’s left
shoulder was noted to be limited due to pain. Ex. 3 at 298. A left shoulder x-ray
revealed only mild degenerative joint changes and a chest CT showed a lipoma on her
back. Id. The examining physician determined that petitioner had “shoulder pain likely
related to rotator cuff pathology, possibly related to large lipoma” and suggested she
continue with pain medications. Id. Petitioner was discharged and directed to follow up
with her primary care physician. Id. at 296.
Petitioner followed up with another physician at Mercy Hospital, Kimberly
Townsend-Scott, M.D., on January 26, 2016, complaining of left shoulder pain. Ex. 3 at
326. Dr. Townsend-Scott reviewed the test results from the ER visit and referred
petitioner to a surgeon for evaluation and possible excision of the lipoma. Id. She
suggested physical therapy (“PT”) if petitioner’s symptoms continued following surgery.
Id. at 332.
On February 2, 2016, petitioner sought treatment from an individual she
described as a “natural doctor” at the Center for Progressive Health. Transcript of Fact
Hearing (“Tr.”) 42. At that visit she reported she could not raise her left arm above
horizontal. Ex. 2 at 4. The provider assessed her as having left rotator cuff syndrome
secondary to the vaccines in the left shoulder. Id. at 3.
In response to Dr. Townsend-Scott’s recommendation, petitioner saw a surgeon,
Andrew Perrott, M.D., on February 18, 2016. Ex. 14 at 3. Dr. Perrott examined her
and concluded that excision of the lipoma was “unlikely to change shoulder problem.”
Id. at 4. Dr. Perrott noted restrictions in petitioner’s left shoulder movements with
abduction limited to 60 degrees. Id. He proposed that rotator cuff syndrome might be
the cause of her discomfort and recommended a referral to either an orthopedist or
physical therapy. Id. Petitioner told him she would like to try physical therapy first and
Dr. Perrott placed the order. Id. at 4, 7.
3

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 4 of 15
Petitioner reported to physical therapy (“PT”) on March 28, 2016 for an initial
evaluation. Ex. 5 at 54. She rated her pain at a 7/10 and described having pain with
movement. Id. The physical therapist, Shawn White, P.T., assessed her with left
shoulder ROM limitations. Her flexion ROM was limited to “86 degrees with pain” and
her abduction ROM was limited to “60 degrees with pain.” Id. at 55. Mr. White rated
petitioner’s left upper extremity strength as only “fair” and noted she had tenderness
with palpation over the left deltoid insertion and upper trapezius muscle. Id. He noted
she had positive signs on Hawkins and Kennedy impingement tests. Id. In his overall
assessment, Mr. White wrote that petitioner had “difficulty with ADLs and functional
task[s] of reaching, washing hair, pulling and carrying items that are 10 lbs. or more.”
Id. at 56.
Petitioner returned to see Mr. White on April 26, 2016. Ex. 5 at 20. She initially
reported moderate pain, rating it as 5/10. Id. She experienced some pain relief and
increased ROM in her left shoulder flexion and abduction as a result of the session. Id.
at 21. On April 28, 2016, she rated her pain at 1/10 but she denied improvement with
left shoulder ROM. Id. at 22. Mr. White instructed her to perform shoulder exercises
and stretches at home. Id.
On May 3, 2016, petitioner reported decreased pain and improved range of
motion at PT. Ex. 5 at 30. She rated her left shoulder pain at 0/10 on May 5, 2016 and
said she only had pain with strenuous activity. Id. at 32. Petitioner reported on May 10,
2016 that she was “now able to take her coat off without pain in her [left] shoulder”
although Mr. White noted that she had pain during the PT session. Id. at 34. On May
19, 2016, petitioner told Mr. White she had pain above her left clavicle over the
weekend, but it decreased when she rubbed the spot. Id. at 38. Mr. White noted she
also had pain with manual therapy during the session and she seemed to have
increased fluid in her left shoulder compared to previous sessions. Id. at 38. She rated
her pain level at 1/10 when she returned to PT on May 24, 2016 but by June 7, 2016,
she again reported a pain score of 0/10. Id. at 39, 5.
Petitioner attended a total of 12 PT sessions with Mr. White and was discharged
on June 9, 2016. Ex. 5 at 7-57. At the final PT session, petitioner said she was feeling
well with no left shoulder pain. Id. at 7. Her active ROM had improved but was still
limited to 95 degrees in flexion and 93 degrees in abduction. Id. at 8. Mr. White noted
the following in the discharge assessment:
Upon discharge patient is able to perform increased ADLs including ease in
putting on bra, zipping dresses, and donning jackets. Patient has increased
ROM of [left] shoulder compared to initial evaluation in shoulder flexion and
abduction. Patient has decreased pain of 0/10 in [left] shoulder compared
to a 7/10 achy pain in the shoulder during initial evaluation on March 28,
2016. Patient showed a decrease in functional limitations with Shoulder
Pain and Disability Index from 86.9% to 79% upon discharge. Patient is
now [independent] with [home exercise program] and instructed to continue
4

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 5 of 15
home exercises and stretches to continue to decrease functional
impairment in [left] shoulder.
Id. at 9.
Petitioner mentioned her left shoulder condition at appointments with several
other providers but did not receive treatment. For example, she presented to Universal
City Family Practice on April 18, 2016 to follow up on some unrelated labs. Ex. 7 at 3.
The notes from the visit were handwritten and are difficult to read but there seems to be
a notation about a left shoulder problem. Id. at 4. It appears no treatment was
suggested for the left shoulder. Id.
On November 7, 2016, petitioner was seen by a rheumatologist, Rediet Kokebie,
M.D., for right wrist and right knee pain. Ex. 10 at 1. Petitioner attributed the right wrist
pain to overuse of the right arm to protect the vaccine-injured left shoulder. Dr. Kokebie
did not address the left shoulder condition other than to note petitioner’s account. Id. at
1, 2.
Finally, petitioner sought an evaluation of her left shoulder pain and her back
lipoma from an orthopedist, Ellis Nam, M.D., on March 8, 2018. Ex. 23 at 3. Dr. Nam
noted her history of left shoulder pain after a vaccination and that she had PT for about
three months that helped her pain. Dr. Nam added that she still had some weakness
and loss of range of motion. Id. After examining petitioner, Dr. Nam found her shoulder
area nontender, determined that she had good passive ROM but positive impingement,
and noted a weak rotator cuff. Id. at 4. He assessed her with left shoulder pain, status
post vaccination in October 2015, with a possible cuff tear. He recommended an MRI to
rule out a rotator cuff tear, but she elected not to proceed. Id. at 4.
III. Testimony and Affidavit
Petitioner described her vaccination experience and her subsequent left shoulder
pain and suffering in an affidavit filed in this case. Ex. 15. She also testified at length at
a fact hearing on September 18, 2018 about her attempts to obtain treatment for the left
shoulder injury and her current limitations.
Petitioner recalled in her affidavit that she experienced pain and inflammation
almost immediately after receiving the vaccinations in her left arm. Ex. 15 at 2. She
asked the clinic technician about the pain and was advised it was normal and would
subside in a couple of days. Id. at 2; Tr. 11. She noticed swelling around the injection
site after she left the clinic. Ex. 15 at 2. The pain worsened the following day and she
had difficulty moving her arm. Ex. 15 at 2. She called the clinic and was told it might
take a couple of weeks to resolve. Id. at 2-3.
Petitioner stated in her affidavit that in the week following the vaccinations, she
“could not move [her] left arm nearly at all, and it was basically incapacitated from that
point onward.” Ex. 15 at 3. She called the clinic after two weeks because the pain and
immobility had continued. Id. She was told again that the symptoms should go away.
5

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 6 of 15
Id. Petitioner testified that she took aspirin and wore an “ion bracelet” and an “impulse
stimulator” to ease the pain that she described as “unbearable.” Tr. 15. She contacted
her primary care physician, Dr. Noriega, but could not schedule an appointment until
late December. Id at 15-16.
When petitioner saw Dr. Noriega on December 22, 2015, she could not lift her
left arm which interfered with dressing and bathing. Tr. 18. Dr. Noriega referred her for
a test, but it was not covered by insurance. Ex. 15 at 3. Petitioner became frustrated
with the pain, sleeplessness, and immobility of her left arm so she went to the
emergency room on January 19, 2016. Ex. 15 at 3-4; Tr. 23. The CT scan showed a
lipoma on petitioner’s back leading to uncertainty regarding her diagnosis and she was
discharged with pain medication and instructions to return if symptoms worsened. Ex.
15 at 4; Tr. 24.
Petitioner testified that she went to the Center for Progressive Health in February
2016 and paid out of pocket because she was determined to find out what was going on
with her left shoulder. Tr. 42. The “natural doctor” at the center told her that she had an
issue with her rotator cuff. Id.
Petitioner’s left arm was still painful with limited functioning when she went to the
PT evaluation on March 28, 2016. Tr. 38. She could not get in the tub, reach her pots
and pans, put on a necklace, or fasten her bra. Tr. 38-39. The PT helped petitioner
with the pain, and she regained use of her arm although she still has limitations. Tr. 45.
Petitioner testified that she purchased an exercise device called the Euro Shaper
in order to exercise at home because she was concerned about going to the gym and
further injuring her shoulder. Tr. 43. She expressed a belief that the device would
assist in healing her shoulder condition but acknowledged that it was not prescribed or
recommended by her physicians. Tr. 43, 68. The date of the purchase was May 23,
2016. Ex. 26 at 2.
Petitioner testified that she sought out Dr. Nam in 2018 to clarify whether the
lipoma was the cause of her symptoms and he told her she had a rotator cuff tear and
should get an MRI. She chose not to get an MRI because the left shoulder pain was
gone, and she wanted to forget about it. Tr. 51.
Petitioner described her experience as pain that she would not wish “on [her]
worst enemy, because it took [her] through hell.” Tr. 53. She also testified that
currently she “can do everything practically that [she] used to” except for reaching for
her pots and pans. Tr. 48-49.
Upon request from the undersigned at the fact hearing, petitioner demonstrated
that the flexion and abduction range of motion of her left arm was limited to 90 degrees
or less. She was unable to reach the back of her bra strap with her left hand. Tr. 80-81.
The undersigned determined at the hearing that petitioner’s testimony was consistent
and credible as to the pain, weakness, and reduced range of motion that she
experienced. Tr. 84.
6

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 7 of 15
IV. The Parties’ Arguments
Petitioner proposes damages in the amount of $100,000.00 for her actual pain
and suffering and $1,300.00 in unreimburseable expenses including $200.00 for a
medical appointment at the Center for Progressive Health and $1,100.00 for an item of
“rehabilitation exercise equipment.” Memorandum of Law in Support of Petitioner’s
Motion for Finding of Fact Regarding Damages (“Pet. Mem.”) at 4 (ECF No. 76).
Petitioner did not make a claim for lost wages.
In support of the amount suggested for her pain and suffering, petitioner makes
passing reference to the Court’s rulings on damages over the last year but cites no
cases. Pet. Mem. at 5. Petitioner also emphasizes that she continues to experience
“residual deficits in strength, range of motion, and ability with her left arm, as was
visually demonstrated at the fact hearing.” Id.
Respondent argues that petitioner should be awarded $50,000.00 as
compensation for her actual pain and suffering. Respondent’s Brief on Damages (“Res.
Brief”) at 1 (ECF No. 77). To justify this lower amount, respondent emphasizes that
petitioner did not obtain medical care until almost two months after the causal
vaccination, took no pain medications other than aspirin, and was treated with ten PT
sessions after which her left shoulder was significantly improved.5 Respondent further
asserts that petitioner’s SIRVA was not severe and to the extent that it has not resolved,
is only mildly limiting at present. Res. Brief at 8.
Respondent compares petitioner’s SIRVA to those suffered by petitioners in
Knauss and Crefasi.6 Res. Brief at 9. He argues the facts in this case are most like
those in Knauss where the petitioner was awarded $60,000.00 for pain and suffering.
Id. Respondent also relies on a syncope case involving a fractured skull, purportedly for
context.7 Id. at 8-9.
V. Legal Standard
Compensation awarded pursuant to the Vaccine Act shall include “[f]or actual
and projected pain and suffering and emotional distress from the vaccine-related injury,
an award not to exceed $250,000.” § 15(a)(4). Additionally, petitioner may recover
“actual unreimbursable expenses incurred before the date of judgment award such
expenses which (i) resulted from the vaccine-related injury for which petitioner seeks
compensation, (ii) were incurred by or on behalf of the person who suffered such injury,
5 Petitioner had 12 sessions of physical therapy. See Ex. 5 at 5-57.
6 Knauss v. Sec’y of Health & Human Servs., No. 16-1372V, 2018 WL 3432906 (Fed. Cl. Spec. Mstr. May
23, 2018) (awarding $60,000.00 for pain and suffering and $170.00 in unreimbursable medical
expenses); Crefasi v. Sec’y of Health & Human Serv., No. 15-166V, 2015 WL 5166283 (Fed. Cl. Spec.
Mstr. Aug. 12, 2015) (awarding $50,000.00 pursuant to proffer).
7 H.S. v. Sec’y of Health & Human Serv., No. 14-1057V, 2015 WL 6155891 (Fed. Cl. Spec. Mstr. Sept.
25, 2015) (awarding $60,000.00 for pain and suffering).
7

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 8 of 15
and (iii) were for diagnosis, medical or other remedial care, rehabilitation . . . determined
to be reasonably necessary.” § 15(a)(1)(B). Petitioner bears the burden of proof with
respect to each element of compensation requested. Brewer v. Sec’y of Health &
Human Servs., No. 93-0092V, 1996 WL 147722, at *22-23 (Fed. Cl. Spec. Mstr. Mar.
18, 1996).
There is no formula for assigning a monetary value to a person’s pain and
suffering and emotional distress. I.D. v. Sec’y of Health & Human Servs., No. 04-
1593V, 2013 WL 2448125, at *9 (Fed. Cl. Spec. Mstr. May 14, 2013) (“Awards for
emotional distress are inherently subjective and cannot be determined by using a
mathematical formula”); Stansfield v. Sec’y of Health & Human Servs., No. 93-0172V,
1996 WL 300594, at *3 (Fed. Cl. Spec. Mstr. May 22, 1996) (“the assessment of pain
and suffering is inherently a subjective evaluation”). Factors to be considered when
determining an award for pain and suffering include: 1) awareness of the injury; 2)
severity of the injury; and 3) duration of the suffering. I.D., 2013 WL 2448125, at *9
(quoting McAllister v. Sec’y of Health & Human Servs., No 91-1037V, 1993 WL 777030,
at *3 (Fed. Cl. Spec. Mstr. Mar. 26, 1993), vacated and remanded on other grounds, 70
F.3d 1240 (Fed. Cir. 1995)).
The undersigned may also look to prior pain and suffering awards to aid in her
resolution of the appropriate amount of compensation for pain and suffering in this case.
See, e.g., Doe 34 v. Sec’y of Health & Human Servs., 87 Fed. Cl. 758, 768 (2009)
(finding that “there is nothing improper in the chief special master’s decision to refer to
damages for pain and suffering awarded in other cases as an aid in determining the
proper amount of damages in this case.”). And, of course, the undersigned may also
rely on her own experience adjudicating similar claims.8 Hodges v. Sec’y of Health &
Human Servs., 9 F.3d 958, 961 (Fed. Cir. 1993) (noting that Congress contemplated the
special masters would use their accumulated expertise in the field of vaccine injuries to
judge the merits of individual claims). Importantly, however, it must also be stressed
that pain and suffering is not determined based on a continuum. See Graves v. Sec’y of
Health & Human Servs., 109 Fed. Cl. 579 (2013).
In Graves, Judge Merrow rejected the special master’s approach of awarding
compensation for pain and suffering based on a spectrum from $0.00 to the statutory
$250,000.00 cap. Judge Merrow noted that this constituted “the forcing of all suffering
awards into a global comparative scale in which the individual petitioner’s suffering is
compared to the most extreme cases and reduced accordingly.” Graves, 109 Fed. Cl.
at 590. Instead, Judge Merrow assessed pain and suffering by looking to the record
evidence, prior pain and suffering awards within the Vaccine Program, and a survey of
similar injury claims outside of the Vaccine Program. Id. at 595.
VI. Prior SIRVA Compensation
8 From July 2014 until September 2015, the SPU was overseen by former Chief Special Master Vowell.
Since that time, all SPU cases, including the majority of SIRVA claims, have remained on the
undersigned’s docket.
8

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 9 of 15
A. History of SIRVA Settlement and Proffer9
SIRVA cases have an extensive history of informal resolution within the SPU. As
of July 1, 2019, 1,170 SIRVA cases have informally resolved10 within the SPU since its
inception in July of 2014. Of those cases, 689 resolved via the government’s proffer on
award of compensation, following a prior ruling that petitioner is entitled to
compensation.11 Additionally, 462 SPU SIRVA cases resolved via stipulated agreement
of the parties without a prior ruling on entitlement.
Among the SPU SIRVA cases resolved via government proffer, awards have
typically ranged from $75,325.00 to $124,442.25.12 The median award is $96,223.27.
Formerly, these awards were presented by the parties as a total agreed upon dollar
figure without separately listed amounts for expenses, lost wages, or pain and suffering.
Since late 2017, the government’s proffer has included subtotals for each type of
compensation awarded.
Among SPU SIRVA cases resolved via stipulation, awards have typically ranged
from $50,000.00 to $95,000.00.13 The median award is $70,000.00. In most instances,
the parties continue to present the stipulated award as a total agreed upon dollar figure
without separately listed amounts for expenses, lost wages, or pain and suffering.
Unlike the proffered awards, which purportedly represent full compensation for all of
petitioner’s damages, stipulated awards also typically represent some degree of
litigative risk negotiated by the parties.
B. Prior Decisions Addressing SIRVA Damages
9 Prior decisions awarding damages, including those resolved by settlement or proffer, are made public
and can be searched on the U.S. Court of Federal Claims website by keyword and/or by special master.
On the court’s main page, click on “Opinions/Orders” to access the database. All figures included in this
order are derived from a review of the decisions awarding damages within the SPU. All decisions
reviewed are, or will be, available publicly. All figures and calculations cited are approximate.
10 Additionally, 36 claims alleging SIRVA have been dismissed within the SPU.
11 Additionally, there have been 19 prior cases in which petitioner was found to be entitled to
compensation, but where damages were resolved via a stipulated agreement by the parties rather than
government proffer.
12 Typical range refers to cases between the first and third quartiles. Additional outlier awards also exist.
The full range of awards spans from $25,000.00 to $1,845,047.00. Among the 19 SPU SIRVA cases
resolved via stipulation following a finding of entitlement, awards range from $45,000.00 to $1,500,000.00
with a median award of $115,772.83. For these awards, the first and third quartiles range from
$90,000.00 to $160,502.39.
13 Typical range refers to cases within the second and third quartiles. Additional outlier awards also exist.
The full range of awards spans from $5,000.00 to $509,552.31. Additionally, two stipulated awards were
limited to annuities, the exact amounts of which were not determined at the time of judgment.
9

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 10 of 15
In addition to the extensive history of informal resolution, the undersigned has
also issued 19 reasoned decisions as of the end of May of 2019 addressing the
appropriate amount of compensation in prior SIRVA cases within the SPU.14
i. Below-median awards limited to past pain and suffering
In 11 prior SPU cases, the undersigned has awarded compensation for pain and
suffering limited to compensation for actual or past pain and suffering that has fallen
below the amount of the median proffer discussed above. These awards for actual pain
and suffering ranged from $60,000.00 to $90,000.00.15 These cases have all included
injuries with a “good” prognosis, albeit in some instances with some residual pain. All of
these cases had only mild to moderate limitations in range of motion and MRI imaging
likewise showed only evidence of mild to moderate pathologies such as tendinosis,
bursitis, or edema. The duration of injury ranged from six to 29 months and, on
average, these petitioners experienced approximately 14 months of pain.
Significant pain was reported in these cases for up to eight months. However, in
approximately half of the cases, these petitioners subjectively rated their pain as six or
below on a ten-point scale. Petitioners who reported pain in the upper end of the ten-
point scale generally suffered pain at this level for three months or less. Approximately
one-half were administered one to two cortisone injections. Most of these petitioners
14 An additional case, Young v. Sec’y of Health & Human Servs., No. 15-1241V, was removed from the
SPU due to the protracted nature of the damages phase of that case. In that case the undersigned
awarded $100,000.00 in compensation for past pain and suffering and $2,293.15 for past unreimbursable
expenses. 2019 WL 664495 (Fed. Cl. Spec. Mstr. Jan. 22, 2019). A separate reasoned ruling addressed
the amount awarded. 2019 WL 396981 (Fed. Cl. Spec. Mstr. Jan. 4, 2019).
15 These cases are: Bruegging v. Sec’y of Health & Human Servs., No. 17-0261V, 2019 WL 2620957
(Fed. Cl. Spec. Mstr. May 13, 2019) (awarding $90,000.00 for actual pain and suffering and $1,163.89 for
actual unreimbursable expenses); Pruett v. Sec’y of Health & Human Servs., No. 17-0561V, 2019 WL
3297083 (Fed. Cl. Spec. Mstr. Apr. 30, 2019) (awarding $75,000.00 for actual pain and suffering and
$944.63 for actual unreimbursable expenses); Bordelon v. Sec’y of Health & Human Servs., No. 17-
1892V, 2019 WL 2385896 (Fed. Cl. Spec. Mstr. Apr. 24, 2019) (awarding $75,000.00 for actual pain and
suffering); Weber v. Sec’y of Health & Human Servs., No. 17-0399V, 2019 WL 2521540 (Fed. Cl. Spec.
Mstr. Apr. 9, 2019) (awarding $85,000.00 for actual pain and suffering and $1,027.83 for actual
unreimbursable expenses); Garrett v. Sec’y of Health & Human Servs., No. 18-0490V, 2019 WL 2462953
(Fed. Cl. Spec. Mstr. Apr. 8, 2019) (awarding $70,000.00 for actual pain and suffering); Attig v. Sec’y of
Health & Human Servs., No. 17-1029V, 2019 WL 1749405 (Fed. Cl. Spec. Mstr. Feb. 19, 2019)
(awarding $75,000.00 for pain and suffering and $1,386.97 in unreimbursable medical expenses);
Dirksen v. Sec’y of Health & Human Servs., No. 16-1461V, 2018 WL 6293201 (Fed. Cl. Spec. Mstr. Oct.
18, 2018) (awarding $85,000.00 for pain and suffering and $1,784.56 in unreimbursable medical
expenses); Kim v. Sec’y of Health & Human Servs., No. 17-0418V, 2018 WL 3991022 (Fed. Cl. Spec.
Mstr. July 20, 2018) (awarding $75,000.00 for pain and suffering and $520.00 in unreimbursable medical
expenses); Knauss v. Sec’y of Health & Human Servs., No. 16-1372V, 2018 WL 3432906 (Fed. Cl. Spec.
Mstr. May 23, 2018) (awarding $60,000.00 for pain and suffering and $170.00 in unreimbursable medical
expenses); Marino v. Sec’y of Health & Human Servs., No. 16-0622V, 2018 WL 2224736 (Fed. Cl. Spec.
Mstr. Mar. 26, 2018) (awarding $75,000.00 for pain and suffering and $88.88 in unreimbursable medical
expenses); Desrosiers v. Sec’y of Health & Human Servs., No. 16-0224V, 2017 WL 5507804 (Fed. Cl.
Spec. Mstr. Sept. 19, 2017) (awarding $85,000.00 for pain and suffering and $336.20 in past
unreimbursable medical expenses).
10

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 11 of 15
pursued physical therapy for two months or less and none had any surgery. The
petitioners in Weber and Garrett attended PT for five and four months respectively, but
most of the PT in Weber focused on conditions unrelated to the petitioner’s SIRVA.
Several of these cases (Knauss, Marino, Kim, and Dirksen) included a delay in seeking
treatment. These delays ranged from about 42 days in Kim to over six months in
Marino.
ii. Above-median awards limited to past pain and suffering
Additionally, in five prior SPU cases, the undersigned has awarded
compensation limited to past pain and suffering falling above the median proffered
SIRVA award. These awards have ranged from $110,000.00 to $160,000.00.16 Like
those in the preceding group, prognosis was “good.” However, as compared to those
petitioners receiving a below-median award, these cases were characterized either by a
longer duration of injury or by the need for surgical repair. Four out of five underwent
some form of shoulder surgery while the fifth (Cooper) experienced two full years of
pain and suffering, eight months of which were considered significant, while seeking
extended conservative treatment. On the whole, MRI imaging in these cases also
showed more significant findings. In four out of five cases, MRI imaging showed
possible evidence of partial tearing.17 No MRI study was performed in the Cooper case.
During treatment, each of these petitioners subjectively rated their pain within the
upper half of a ten-point pain scale and all experienced moderate to severe limitations in
range of motion. Moreover, these petitioners tended to seek treatment of their injuries
more immediately. Time to first treatment ranged from five days to 43 days. Duration of
physical therapy ranged from one to 24 months and three out of the five had cortisone
injections.
16 These cases are: Reed v. Sec’y of Health & Human Servs., No. 16-1670V, 2019 WL 1222925 (Fed. Cl.
Spec. Mstr. Feb. 1, 2019) (awarding $160,000.00 for pain and suffering and $4,931.06 in unreimbursable
medical expenses); Knudson v. Sec’y of Health & Human Servs., No. 17-1004V, 2018 WL 6293381 (Fed.
Cl. Spec. Mstr. Nov. 7, 2018) (awarding $110,000.00 for pain and suffering and $305.07 in
unreimbursable medical expenses); Cooper v. Sec’y of Health & Human Servs., No. 16-1387V, 2018 WL
6288181 (Fed. Cl. Spec. Mstr. Nov. 7, 2018) (awarding $110,000.00 for pain and suffering and $3,642.33
in unreimbursable medical expenses); Dobbins v. Sec’y of Health & Human Servs., No. 16-0854V, 2018
WL 4611267 (Fed. Cl. Spec. Mstr. Aug. 15, 2018) (awarding $125,000.00 for pain and suffering and
$3,143.80 in unreimbursable medical expenses); Collado v. Sec’y of Health & Human Servs., No. 17-
0225V, 2018 WL 3433352 (Fed. Cl. Spec. Mstr. June 6, 2018) (awarding $120,000.00 for pain and
suffering and $772.53 in unreimbursable medical expenses).
17 In Reed, MRI showed edema in the infraspintaus tendon of the right shoulder with a possible tendon
tear and a small bone bruise of the posterior humeral head. In Dobbins, MRI showed a full-thickness
partial tear of the supraspinatus tendon extending to the bursal surface, bursal surface fraying and partial
thickness tear of the tendon, tear of the posterior aspects of the inferior glenohumeral ligament, and
moderate sized joint effusion with synovitis and possible small loose bodies. In Collado, MRI showed a
partial bursal surface tear of the infraspinatus and of the supraspinatus. In Knudson, MRI showed mild
longitudinally oriented partial-thickness tear of the infraspinatus tendon, mild supraspinatus and
infraspinatus tendinopathy, small subcortical cysts and mild subcortical bone marrow edema over the
posterior-superior-lateral aspect of the humeral head adjacent to the infraspinatus tendon insertion site,
and minimal subacromial-subdeltoid bursitis.
11

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 12 of 15
iii. Awards including compensation for both past and future pain
and suffering
In three prior SPU SIRVA cases, the undersigned has awarded compensation for
both past and future pain and suffering.18 In two of those cases (Hooper and Binette),
petitioners experienced moderate to severe limitations in range of motion and moderate
to severe pain. The Hooper petitioner underwent surgery while in Binette petitioner was
deemed not a candidate for surgery following an arthrogram. Despite significant
physical therapy (and surgery in Hooper), medical opinion indicated that their disability
would be permanent. In these two cases, petitioners were awarded above-median
awards for actual pain and suffering as well as awards for projected pain and suffering
for the duration of their life expectancies. In the third case (Dhanoa), petitioner’s injury
was less severe than in Hooper or Binette; however, petitioner had been actively
treating just prior to the case becoming ripe for decision and her medical records
reflected that she was still symptomatic despite a good prognosis. The undersigned
awarded an amount below-median for actual pain and suffering, but, in light of the facts
and circumstances of the case, also awarded projected pain and suffering.
VII. Appropriate Compensation in this SIRVA Case
A. Past Pain and Suffering
In this case, awareness of the injury is not in dispute. The record reflects that at
all relevant times petitioner was a competent adult with no impairments that would
impact her awareness of her injury. Therefore, the undersigned’s analysis will focus
principally on the severity and duration of petitioner’s injury.
Petitioner received a vaccine on October 19, 2015 and suffered pain in her left
shoulder that was immediate and severe. Ex. 15 at 2-3. She testified that she tried to
obtain medical attention for the painful symptoms within days and weeks of the
vaccination but was unable to see her primary care physician until two months after the
vaccination. Tr. 12-13. She described how she took measures on her own to obtain
relief from the pain by taking aspirin and wearing an “ion bracelet” and an “impulse
stimulator.” Tr. 15. She testified that the pain “took [her] through hell” and she would
not wish it “on [her] worst enemy.” Tr. 53.
When petitioner’s primary care physician proved unhelpful in diagnosing and
treating her left shoulder, she went to the emergency room to find out what was wrong
18 These cases are: Dhanoa v. Sec’y of Health & Human Servs., No. 15-1011V, 2018 WL 1221922 (Fed.
Cl. Spec. Mstr. Feb. 1, 2018) (awarding $85,000.00 for actual pain and suffering, $10,000.00 for projected
pain and suffering for one year, and $862.15 in past unreimbursable medical expenses); Binette v. Sec’y
of Health & Human Servs., No. 16-0731V, 2019 WL 1552620 (Fed. Cl. Spec. Mstr. Mar. 20, 2019)
(awarding $130,000.00 for actual pain and suffering, $1,000.00 per year for a life expectancy of 57 years
for projected pain and suffering, and $7,101.98 for past unreimbursable medical expenses); and Hooper
v. Sec’y of Health & Human Servs., No. 17-0012V, 2019 WL 1561519 (Fed. Cl. Spec. Mstr. Mar. 20,
2019) (awarding $185,000.00 for actual pain and suffering, $1,500.00 per year for a life expectancy of 30
years for projected pain and suffering, $37,921.48 for lost wages).
12

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 13 of 15
and to obtain relief from the pain. Ex. 15 at 3-4; Ex. 3 at 278, 298. When that effort was
also unsuccessful, she paid out of pocket to see a “natural doctor.” Tr. 42. Finally, she
saw a surgeon who recommended physical therapy which ultimately resolved the pain.
Ex. 14 at 4; Tr. 45.
Petitioner described moderate to severe pain in her left shoulder to her medical
providers from December 2015 through April 2016. She rated her pain as 6/10 to Dr.
Noriega on December 22, 2015 and rated the pain as 7/10 at the PT evaluation on
March 28, 2016. Ex. 3 at 49; Ex. 5 at 54. After several sessions of PT, she rated her
pain as 5/10 on April 26, 2016. Ex. 5 at 55. Subsequently her pain mostly resolved as
a result of PT and home exercise program. She reported pain levels of 0-1/10 at PT in
May and June 2016. Ex. 5 at 10, 41, She testified at the fact hearing on September 18,
2018 that the left shoulder pain had gotten better. Tr. 45.
Petitioner also suffered from ROM restrictions in her left shoulder starting shortly
after the vaccination. Ex. 15 at 3. She testified the restrictions were severe and
interfered with dressing, bathing, and cooking. Tr. 38-39. PT helped with the restricted
ROM but, upon discharge, the physical therapist recommended continued home
exercises and stretches to keep improving. Ex. 5 at 9. At the fact hearing, petitioner
demonstrated that she still could not move her left arm past 90 degrees in flexion and
abduction. Tr. 80-81.
Petitioner’s case is similar to the prior SPU cases with below-median awards for
past pain and suffering. Petitioners in these cases tended to have moderate symptoms
with good results from treatment and did not require surgery. The awards in these
cases ranged from $60,000.00 to $90,000.00. Petitioner’s case is most like the facts
found in Kim. The petitioner in Kim sought treatment 42 days after vaccination, had
three months of significant pain (rated at 7-10/10), and her symptoms mostly resolved
after 11 sessions of PT over several months. She had a good prognosis with some
remaining pain and stiffness. The petitioner in Kim was awarded $75,000.00 in pain
and suffering.19
Respondent primarily relies on Knauss to support his proposed award of
$50,000.00. However, the petitioner in Knauss was awarded $60,000.00 and he rarely
rated his pain higher than 1/10. 20 He continued swimming and performing yard work
while undergoing treatment and went for extended periods of time without treatment. Id.
This suggests his symptoms were milder and interfered less with his daily activities than
the petitioner in the instant case.
There is preponderant evidence to establish petitioner suffered moderate to
severe symptoms of her SIRVA, including significant pain and limited ROM, for six
months after vaccination. By the end of this period she showed substantial
improvement. She completed PT on June 9, 2016 and was reporting no pain but some
residual limitations in her ROM. Ex. 5 at 9. Although she complained of weakness and
loss of motion in the left shoulder in a medical visit on March 8, 2018, she elected not to
19 Kim, 2018 WL 3991022, at *1-3
20 Knauss, 2018 WL 3432906 at *7-8.
13

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 14 of 15
undergo treatment for it. Ex. 23 at 4. Her active treatment for the left shoulder
concluded on June 9, 2016, eight months after the vaccination.
Looking at the totality of circumstances, including the severity of petitioner’s initial
pain and suffering and limited ROM, the undersigned finds $75,000 to be an appropriate
amount for petitioner’s pain and suffering.
B. Future Pain and Suffering
Petitioner mentions future pain and suffering in her brief as being compensable
under the Vaccine Act without making a specific request or providing supporting
evidence. Pet. Mem. at 5. Rather, petitioner emphasizes that she continues to
experience residual deficits. She claims to have provided ample evidence of pain and
suffering from the time of onset to the time of the fact hearing. Id.
The record shows that petitioner obtained significant relief from physical therapy.
She has not sought further treatment for her left shoulder since her discharge from PT
other than a consultation in 2018. Ex. 5 at 9; Ex. 23 at 4. At that consult, an MRI was
recommended, but petitioner elected not to proceed because her pain was gone. Id.
The undersigned finds that petitioner has not met her burden of establishing by
preponderant evidence that she is entitled to an award for future pain and suffering.
C. Award for Past Unreimbursed Expenses
Petitioner requests reimbursement for two expenses and provided receipts to
support the request. Pet. Mem. at 4; Ex. 26 at 1-3. The first receipt is for a $200.00
payment to the Center for Progressive Health. Ex. 26 at 1. Petitioner testified at the
fact hearing that she went to the Center for Progressive Health to obtain treatment for
her left shoulder pain. Petitioner has submitted medical records documenting the visit.
Tr. 42; Ex. 2 at 1-4. Respondent confirmed in his damages brief that he has no
objection to this payment. Res. Brief at 10.
Petitioner’s second receipt is for $1,100.00 for an item of exercise equipment
called a Euro Body Shaper. Ex. 26 at 2-3. Petitioner claims in her damages brief that
she purchased the item for the purpose of performing rehabilitation exercises at home
“in order to recover from her injury in a safe environment.” Pet. Mem. at 4. Petitioner
testified at the fact hearing that she bought the item because she could not go to the
gym and exercise out of fear that someone would hit her shoulder. Tr. 43. She also
testified that she believed the device would help her shoulder because it was supposed
to “improve your blood circulation and lymphatic system.” Id. She conceded that she
did not buy it at the recommendation of any of her medical providers. Id. Petitioner did
not provide evidence, other than her own opinion, that the Euro Body Shaper was
special equipment that was “reasonably necessary” for diagnosis, medical treatment, or
rehabilitation of her injured left shoulder as required in § 15(a)(1)(B)(iii).
Considering the above, the undersigned awards $200.00 in past unreimbursed
expenses for the medical visit to the Center for Progressive Health. The undersigned
14

Case 1:16-vv-01458-UNJ Document 82 Filed 11/15/19 Page 15 of 15
finds that petitioner has not met her burden of establishing by preponderant evidence
that the Euro Body Shaper was reasonably necessary for diagnosis, treatment, or
rehabilitation of her left shoulder.
VIII. Conclusion
For all of the reasons discussed above and based on consideration of the record
as a whole, the undersigned finds that $75,000.00 represents a fair and
appropriate amount of compensation for petitioner’s actual pain and suffering.21
The undersigned also finds that petitioner is entitled to $200.00 in actual
unreimbursable expenses.
Based on the record as a whole and arguments of the parties, the undersigned
awards petitioner a lump sum payment of $75,200.00 in the form of a check
payable to petitioner, Denise Goring. This amount represents compensation for all
damages that would be available under § 15(a).
The clerk of the court is directed to enter judgment in accordance with this
decision.22
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
21 Since this amount is being awarded for actual, rather than projected, pain and suffering, no reduction to
net present value is required. See § 15(f)(4)(A); Childers v. Sec’y of Health & Human Servs., No. 96-
0194V, 1999 WL 159844, at *1 (Fed. Cl. Spec. Mstr. Mar. 5, 1999) (citing Youngblood v. Sec’y of Health
& Human Servs., 32 F.3d 552 (Fed. Cir. 1994)).
22 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
15